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ABSTRACT 
STRUCTURE-FUNCTION ANALYSIS OF THE ESSENTIAL ISLET 
REGULATORY FACTOR NKX2.2 
 
JAMES PAPIZAN 
The specification and differentiation of the pancreatic beta cell lineage requires guidance by 
spatiotemporally regulated signaling cues and a highly orchestrated set of transcription factors. 
Defining the factors and their regulatory functions that are required for proper beta cell 
development will enhance our ability to recapitulate these developmental events in vitro to 
generate beta cells from alternate cell sources. The homeodomain transcription factor Nkx2.2 is 
essential for pancreatic endocrine cell development; Nkx2.2-/- mice lack all beta cells and have 
reductions in alpha and pancreatic polypeptide (PP) cells. In place of these cell populations, the 
Nkx2.2-/- null islet is replete with ghrelin-producing epsilon cells. An Nkx2.2-repressor fusion 
protein derivative (Pdx1:Nkx2.2-EnR) expressed in the   Nkx2.2-/- background can fully rescue 
the alpha cell population, but can only specify a few immature beta cells, suggesting that Nkx2.2 
must contain both repressor and activator functions to properly guide beta cell development. 
Accordingly, Nkx2.2 has been shown to be an activator of several beta-cell targets. It has also 
been demonstrated that the corepressor Grg3 is expressed in the endocrine population and can 
physically interact with Nkx2.2, which points toward a mechanism by which Nkx2.2 confers 
transcriptional repression; however, the genes targeted by Nkx2.2/Grg3 are unknown. 
Additionally, how Nkx2.2 can both repress and activate genes in the same cellular context, and 
differentially regulate the same gene in different cellular contexts, is not understood. In this 
dissertation, I sought to determine the regulatory role of Nkx2.2 in the developing pancreas and 
its dependence on Grg interactions, and to elucidate whether post-translational modifications 
   
play a role in modulating Nkx2.2 regulatory activities. By analyzing mice carrying knock-in 
mutations in the Nkx2.2 Grg-interaction domain (Nkx2.2TNmut/TNmut), I show that the interaction 
between Nkx2.2 and Grg protein is required at two developmental stages of beta cell 
development: 1) Grg-mediated Nkx2.2 repression is necessary for correct beta-cell specification, 
and 2) the recruitment of Grg by Nkx2.2 is required to repress Arx in the beta cells to prevent 
beta-to-alpha cell reprogramming. Additionally, by analyzing the Nkx2.2TNmut/TNmut and 
Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice, I have identified several additional genes that may be 
regulated by Grg-mediated Nkx2.2 repression. Finally, I also present data to suggest that Nkx2.2 
protein is phosphorylated, and that the phosphorylation state determines whether Nkx2.2 
functions as an activator or a repressor in a promoter-specific context. These studies have begun 
to elucidate the complex regulatory roles that Nkx2.2 plays in specifying and maintaining the 
beta-cell lineage. Future analyses will help us to better understand the spatiotemporal regulatory 
activities that are required to make and maintain functional beta cells. 
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Diabetes mellitus is a metabolic disorder characterized by hyperglycemia resulting from defects 
in insulin action, insulin production, or both. According to data from the 2011 National Diabetes 
Fact Sheet, there are 25.8 million Americans with diabetes. In 2010 there were 1.9 million new 
cases diagnosed in individuals aged 20 years or older.  These numbers emphasize that there is a 
current, escalating diabetes pandemic, which exacerbates healthcare problems when considering 
diabetes increases the risk of heart disease and stroke, high blood pressure, blindness, kidney 
disease, neuropathy and amputation; diabetes and its complications resulted in a staggering $174 
billion in healthcare expenditure in the United States in 2007. But diabetes is no longer a 
Western problem; the International Diabetes Federation has estimated that there are 336 million 
individuals with diabetes worldwide, and 4.6 million people aged 20-79 died in 2011 from 
diabetes and/or diabetes-related issues, which equates to one death every seven seconds.  
Type 1 diabetes (T1DM) is an autoimmune disease that results in beta cell destruction, and 
symptoms are generally presented early in life. T1DM accounts for 5-10% of all diabetes cases, 
and patients remain dependent on exogenous insulin life-long. Type 2 diabetes (T2DM), the 
most prevalent form of diabetes, results from a peripheral insulin resistance and insufficient 
insulin production by beta cells. In addition to genetic components, factors such as age, 
pregnancy and obesity have been shown to influence the progression of T2DM. The early stages 
of T2DM can be controlled by diet, but ultimately, as the disease progresses and beta cell failure 
ensues, patients become insulin-dependent. However, even with insulin treatment, many patients, 
both T1DM and T2DM, have difficulty maintaining correct blood glucose levels at all times. 
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Additionally, insulin treatment increases the risk of dangerous episodes of hypoglycemia, 
especially when in the hands of young and/or uneducated individuals. These problems have led 
physicians and researchers to explore other avenues of treatment.  
The first pancreas transplant was carried out in 1967 (Kelly et al., 1967). However, due to risks 
associated with major surgery, the isolation and transplantation of pancreatic islets was 
introduced (Ballinger and Lacy, 1972; Scharp et al., 1990), avoiding the need for major 
laparotomy. Further refinements to this protocol (Shapiro et al., 2000) revealed that pancreatic 
islet transplantation was a viable option for T1DM treatment (Ryan et al., 2005; Shapiro et al., 
2006). Islet transplantation has its limitations, however. Not only do recipients require ongoing 
immunosuppressive therapy to prevent rejection, cadaveric donor islets are severely lacking in 
number (Sheehy et al., 2003), and live donors are subjected to risky surgery and are put at risk 
for developing diabetes themselves (Matsumoto et al., 2006; Matsumoto et al., 2005).  These 
impediments have led researchers to investigate other sources of mature, glucose-responsive beta 
cells for the treatment of diabetes.  
Alternate sources of pancreatic beta cells 
The liver: In order to circumvent the aforementioned problems with islet transplantation 
(immunorejection and cadaveric islet availability), many investigators in developmental biology 
and regenerative medicine have focused their efforts on generating functional beta cells from 
alternate sources such as liver, exocrine pancreas, induced pluripotent stem (iPS) cells or 
embryonic stem (ES) cells. The liver is an attractive candidate from which to derive beta cells 
since it is an endoderm-derived organ that shares the nascent developmental program with the 
pancreas (Xu et al., 2011).  
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Many attempts to directly transdifferentiate liver cells to beta cells have been made (Ber et al., 
2003; Kojima et al., 2003; Li, 2009; Nagaya et al., 2009; Tang et al., 2006); however, this 
approach is not achieved without the use of viruses or transgenes and, moreover, the beta-like 
cells that were generated were lacking in numbers and mature, functional markers.  
iPS cells: Zhou and colleagues were able to show the transdifferentiation of pancreatic acinar 
cells into beta-like cells by introducing three key transcription factors, known for individual 
essential roles in proper beta-cell development, into the exocrine pancreas (Zhou et al., 2008). 
This exciting result demonstrated that highly specialized cells in the exocrine pancreas retain 
enough plasticity that when manipulated with just three transcription factors, can change directly 
into another highly specialized cell in vivo. However, the small number of beta-like cells that 
were generated did not coalesce with the other transdifferentiated beta-like cells to form islets. 
Although, these cells did establish intimate contact with the vasculature, suggesting they had the 
capacity to sense fluctuating changes in blood glucose levels. Additionally, this approach was 
achieved by the use of adenoviruses, which may not be a realistic therapeutic option when 
considering the problems associated with the use of viral vectors (Hasbrouck and High, 2008).   
In 2006, Takahashi and Yamanaka made a momentous contribution to the field of stem cell 
biology when they demonstrated that terminally differentiated cells can be reprogrammed to 
pluripotency with the addition of a defined set of transcription factors (Takahashi and Yamanaka, 
2006). In theory, these iPS cells could then be directed toward the beta-cell lineage in culture to 
amass large quantities of beta cells. The use of iPS cells is an appealing alternate source of beta 
cells, in that they circumvent the political and ethical struggles associated with the use of human 
ES cells. iPS cells could also be used to dissect the developmental steps that go awry in many 
genetic diseases, including diabetes. Despite the exciting progress, questions still remain 
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regarding the use of iPS cells: for example, are iPS cells functionally equivalent to embryonic 
stem cells? A recent report illustrates that iPS cells retain an epigenetic memory of the donor 
tissue, which favors their differentiation along the lineage of the donor cell and impedes the 
differentiation along other lineages (Kim et al., 2010). Reports such as these warrant a more 
critical evaluation of iPS cells relative to ES cells.  
Human ES cells: By far, the greatest advances in generating beta cells from alternate sources 
have been made by utilizing human ES cells. The most successful protocol was outlined by 
D’Amour and colleagues, in which human ES cells were first differentiated to definitive 
endoderm (D'Amour et al., 2005). When ES-cell-derived endoderm was further differentiated 
toward the endocrine lineage in vitro, only a small percentage of cells were insulin-positive, they 
were not glucose-responsive, many cells were poly-hormonal, and the majority of the cells were 
ghrelin-positive (D'Amour et al., 2006). Subsequent refinements to the protocol led to the 
development of strategies to induce ES cells to differentiate into endodermal cells capable of 
generating glucose-sensitive, insulin-secreting cells when transplanted into mice (Kroon et al., 
2008). In spite of this compelling work, insulin positive, glucose-sensing cells have yet to be 
generated in vitro. The generation and purification of mature beta cells in vitro is paramount for 
transplantation applications in order to avoid recipient teratoma formations, which occur after 
implantation of multipotent progenitor endoderm (Kroon et al., 2008).  However, this exciting 
work by Kroon et al. begs the question: What is happening in vivo that directs the transplanted 
endoderm to ostensibly functioning beta cells? What are these in vivo potentiating and 
maturation signals that promote the differentiation of the transplanted endoderm down the beta-
cell lineage, and which seem to be lacking or improperly applied in the in vitro protocols?  
Although the advances in stem-cell directed differentiation are in many ways directly attributable 
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to our increased understanding of pancreatic development, the inability to generate a fully 
functional beta cell in vitro suggests that there is still much to be learned regarding how 
developmental processes guide pancreatic specification, endocrine differentiation and beta cell 
maturation.  
Pancreas development 
Pancreas specification and outgrowth 
The pancreas is a bivalent organ with both exocrine and endocrine functions. The exocrine tissue 
consists of acinar cells that synthesize and secrete digestive juices into the duodenum by way of 
pancreatic ducts, while the endocrine pancreas is made up of islets of Langerhans that sense 
fluctuations in blood glucose and release hormones via fenestrated connections with the islet 
vascular capillary bed into the bloodstream to maintain glucose homeostasis.  
The development of the mature pancreas involves a carefully organized series of embryological 
events that consist of appropriately timed external signaling cascades and a hierarchy of 
transcriptional regulation. The first morphological evidence of pancreas development occurs 
around embryonic day 8.5 (e8.5) as buds of thickening mesenchyme on the dorsal and ventral 
aspects of the primitive gut tube, just distal to the stomach. Around e9.0, the underlying 
endoderm evaginates into the mesenchyme with subsequent plexus formation, which eventually 
expands to a fully differentiated, functional organ. The position and competence of early 
pancreatic buds are influenced by specific inductive and permissive interactions from 
neighboring tissues (Zaret and Grompe, 2008), as long as the endoderm is competent to respond 
to these signals; therefore, pancreas specification is dependent upon endodermal patterning itself 
(Grapin-Botton and Melton, 2000). Proper endodermal patterning will refine gene expression 
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domains along the anterior-posterior (A-P) and dorsal-ventral axes that distinguish the pancreas 
lineage from other endodermal-derived organs, such as the lungs, liver, thyroid, thymus, biliary 
system and digestive tract.  
The definitive endoderm begins as a flat sheet of cells at the beginning of gastrulation, and 
multiple studies using different developmental systems have shown critical roles for Nodal (a 
TGF-beta superfamily member with powerful dose-dependent inductive effects) in the 
development of endoderm. In Xenopus (Clements et al., 1999; Green and Smith, 1990) and 
zebrafish (Shen, 2007) Nodal has been shown to initiate gastrulation and provide a necessary 
gradient for the segregation of mesoderm and endoderm. During gastrulation the endoderm 
establishes the A-P axis, by way of a mechanism that today remains quite vague. Interestingly, 
the endoderm remains plastic along its A-P axis, in that anterior endoderm transplanted to a 
posterior location will acquire a posterior fate, and the same is true when posterior endoderm is 
transplanted into anterior endoderm (Wells and Melton, 2000). The posterior endoderm plasticity 
is lost, however, by early somite stages. This was shown by the inability of the posterior 
endoderm to become anteriorized when transplanted, while the anterior endoderm retained the 
ability to become posteriorized (Kumar et al., 2003). While the understanding of early molecular 
mechanisms controlling endodermal patterning remains incomplete, several signaling pathways 
have been identified that play important roles in this process and pancreas specification, which 
are discussed below.    
Studies in Xenopus have illustrated that pancreas induction is prompted by broad suppression of 
mesodermal WNT signaling in the anterior endoderm, while active mesodermal WNT signaling 
in the posterior endoderm suppresses pancreas induction (McLin et al., 2007; Wells and Melton, 
2000). McLin et al. demonstrated that suppression of WNT is required for the expression of the 
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anterior endoderm marker Hhex, and when WNT is ectopically expressed, there is a loss of 
anterior derived organs, namely the pancreas and liver. It has further been demonstrated that 
Sfrp5, a secreted WNT antagonist, is required to maintain low WNT signaling levels in the 
anterior endoderm, a condition conducive to pancreas specification (Li et al., 2008). However, it 
remains to be determined if pancreas specification requires the complete absence of anterior 
endodermal WNT signaling, or if a low-to-high gradient is needed along the A-P axis.  
During this early specification time window, the dorsal and ventral pancreatic domains are 
exposed to different inductive stimuli. From the time of gut tube formation to about e8.0, Sonic 
hedgehog (Shh) is broadly expressed in the developing endoderm but is excluded from the dorsal 
pre-pancreatic primordium, which is in close apposition with the notochord. This proximity to 
the notochord has been demonstrated to be essential in dorsal bud differentiation; removal of the 
notochord prior to e8.0 results in improper dorsal pancreas formation (Kim et al., 1997).  From 
these and other studies combined, it has been concluded that the notochord dictates dorsal 
pancreatic differentiation most likely by Shh suppression in the pancreatic endoderm. Although 
Shh is secreted from the notochord, the TGFβ signaling molecule Activin-βB is also secreted, 
which has been shown to repress Shh and induce Pdx1 in the dorsal endoderm (Hebrok et al., 
1998). Grafting experiments have shown that notochord can suppress Shh signaling in the lateral 
and ventral endoderm, while notochord deletion results in ectopic Shh expression, accompanied 
by failure of pancreas formation (Hebrok et al., 1998; Hebrok et al., 2000). Accordingly, Shh 
expression driven by the promoter elements of the pancreatic/duodenal progenitor marker, Pdx1, 
severely impairs pancreatic endocrine and exocrine formation (Apelqvist et al., 1997). Around 
e8.0, the paired dorsal aortae fuse at the midline, coming between the notochord and dorsal 
foregut. Lammert et al. have shown a role for this aortic intervention, in that the aortic 
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endothelial cells can induce pancreatic bud-like structures as well as Pdx1 and subsequent insulin 
expression in the adjacent endoderm (Lammert et al., 2001). While the dorsal pancreatic domain 
receives signals from the notochord and dorsal aorta, the formation of the ventral pancreatic 
tissue is under control of the adjacent cardiac mesenchyme and septum transversum mesenchyme. 
During these early events, FGF from the cardiac mesoderm and bone morphogenetic protein 
(BMP) from the septum transversum mesenchyme work in a time- and dose-dependent manner 
to specify the liver fate while suppressing pancreas induction. It is only during foregut closure, 
when ventral endodermal cells migrate caudally to distance themselves from the cardiac 
mesodermal tissue, that these cells escape FGF signals and are allowed to initiate ventral 
pancreas specification (Bort et al., 2004). However, it was recently shown that FGF10 signaling 
through, most likely, the Fgfr2b receptor was necessary to maintain pancreas fate and to prevent 
liver induction in pancreatic Pdx1+ progenitor cells (Seymour et al., 2012). This conclusion was 
derived from conditionally inactivating Sox9 in Pdx1+ cells, which led to an upregulation in 
liver-specific genes and a concomitant decrease in Fgfr2b and Fgfr4, suggesting that Sox9 is 
required to properly regulate Fgfr expression to maintain pancreas identity. Supporting evidence 
using Ptf1a:Cre to excise Sox9, which resulted in a mosaic Sox9 deletion due to sensitivity issues 
at the Sox9FL locus, illustrated that only the cells that lacked Sox9 lacked Fgfr2, while Sox9+ 
cells retained Fgfr2. The authors also demonstrated that FGF10 null mice have a phenotype 
similar to the Pdx1:Cre;Sox9fl/fl mice, which may suggest a Sox9/FGF feed-forward loop. To 
substantiate these claims a closer molecular analysis is needed as well as possible genetic rescue 
experiments, such as overexpressing Sox9 at various times within the FGF10 null background. 
Regardless, the paper presents convincing genetic data and merits further investigations into the 
FGF-mediated pancreas specification mechanism.   
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Retinoic acid (RA) signaling is required for proper development of many organs, and multiple 
systems have demonstrated an essential role for RA in pancreas specification, including 
zebrafish (Stafford and Prince, 2002), Xenopus (Chen et al., 2004; Stafford et al., 2004) and 
mouse (Martin et al., 2005; Molotkov et al., 2005). These investigations have shown that the RA-
synthesizing enzyme, retinaldehyde dehydrogenase 2 (Raldh2), is required for Pdx1 induction 
and dorsal pancreas development. Raldh2 is expressed as early as e7.5 in the mesendoderm and 
becomes localized to lateral plate and paraxial mesoderm during segmentation. Kumar et al., 
using chick embryo in vitro tissue recombination, have shown that signals coming from lateral 
plate mesoderm instruct the adjacent endoderm toward a pancreatic fate. They further 
demonstrated that RA is sufficient to induce Pdx1 expression in endoderm, but only when co-
cultured with mesoderm, suggesting RA is acting indirectly through the mesoderm or response to 
RA-signaling depends on signals from the mesoderm (Kumar et al., 2003). However, Stafford et 
al. show RA, from paraxial mesoderm, signals directly to zebrafish endoderm by using a cell 
transplantation technique in which the ability of SOX32 to confer endodermal identity was used 
to selectively target reagents to the endoderm (Stafford et al., 2006). More recently, Pan et al., 
using tissue recombination experiments in Xenopus, demonstrated that RA signals to the 
endoderm via direct and indirect mechanisms (Pan et al., 2007). A case for RA signaling directly 
to the endoderm is strengthened in a recent study where the RA-degrading enzyme Cyp26, which 
is expressed in the anterior endoderm, is required for the proper size and location of the pre-
pancreatic anlage (Kinkel et al., 2009). In this study, the authors demonstrate that the loss of 
Cyp26 in zebrafish results in a dramatic expansion of pancreatic cell types anteriorly, and 
conclude that the primary role of Cyp26 is to set the boundary of the anterior pancreatic field.  
Ngn3 and endocrine cell commitment  
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Both dorsal and ventral pancreatic buds consist of multipotent progenitor cells (MPCs) marked 
by Pdx1, Ptf1a, Sox9, Nkx6.1/2 and Hnf1β (Haumaitre et al., 2005; Henseleit et al., 2005; 
Kawaguchi et al., 2002; Seymour et al., 2007), which give rise to all adult pancreatic cells types. 
Endocrine cell production first begins in these early buds, generating mainly alpha cells, with 
subsequent formation of beta, delta, PP and epsilon cells (Henseleit et al., 2005; Herrera et al., 
1991; Johansson et al., 2007; Pictet et al., 1972; Prado et al., 2004; Schwitzgebel et al., 2000). 
The fate of these early “first wave” endocrine cells remains a debated issue. While some 
investigators have claimed these first wave endocrine cells are fugacious and do not contribute to 
the adult islet (Herrera, 2000), others have suggested that at least some of them persist and, 
indeed, contribute to the adult islet (Gu et al., 2002; Johansson et al., 2007). If they do persist 
throughout pancreatic development, a remaining question is: how do they become incorporated 
into the orchestrated architecture of the “tip-trunk” branching of the secondary transition, which 
will now be discussed. 
 The secondary transition is a period of massive endocrine cell differentiation. As the pancreatic 
epithelium branches, a pro-acinar domain is formed at the growing tips, and a bi-potential, 
ductal/endocrine compartment is acquired in the extending trunks (Schaffer et al., 2010; Zhou et 
al., 2007). The tip domain is defined by the transcription factors Ptf1a, Cpa1 and Pdx1, while the 
trunk domain expresses Sox9, Nkx6.1, Hnf1β and Pdx1 (Figure 1). The mechanism controlling 
the segregation of the pancreatic epithelium into the tip-trunk domains remains obscure; however, 
evidence illustrating the mutual repressive events between the tip-specific factor Ptf1a and the 
trunk-specific factor Nkx6.1, suggest a mechanism responsible for the development of the tip-
trunk compartmentalization (Krapp et al., 1998; Schaffer et al., 2010). There are additional 
reports of Sox9, Nkx6.1 and Hnf1β all having the ability to bind regulatory regions in Ptf1a 
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(Haumaitre et al., 2005; Lynn et al., 2007; Schaffer et al., 2010), providing further evidence that 
the compartmentalization of the tip-truck domains is acquired through the direct cross repressive 
activities of transcription factors.  
The “second wave” endocrine cells are derived from the bi-potential trunk domain when the 
endocrine progenitor marker Ngn3 is expressed, leading to the subsequent delamination and 
coalescing of these cells into the developing islets (Gu et al., 2002). Notch signaling has been 
shown to play a critical role in this process. The classical lateral inhibition model proposes that 
Ngn3+ cells express the Notch ligand, Delta-like 1 (Dll1), whereas neighboring cells express the 
Notch1 receptor. Upon activation of the Notch receptor via neighboring Ngn3+/Dll1+ cells, the 
intracellular domain of the Notch1 receptor goes through a series of proteolytic cleavages, which 
result in the release of the activated Notch1 intracellular domain (NICD) and its translocation to 
the nucleus where it regulates its target genes, chiefly Hes1 (Apelqvist et al., 1999; Jensen et al., 
2000a; Jensen et al., 2000b). As a strong transcriptional repressor, Hes1 inhibits endocrine cell 
differentiation by binding to and repressing the Ngn3 promoter (Gradwohl et al., 2000; Gu et al., 
2002; Lee et al., 2001). In accordance with the Notch-mediated lateral inhibition model, loss-of-
function studies have demonstrated that the absence of Notch signaling components leads to the 
premature development of endocrine cells (Ahnfelt-Ronne et al., 2012; Apelqvist et al., 1999; 
Jensen et al., 2000b). Conversely, the forced expression of the NICD blocks endocrine cell 
formation (Hald et al., 2003; Murtaugh et al., 2003). In addition, Hes1+ and Ngn3+ cells are 
found in a mosaic expression pattern throughout the pancreatic epithelium (Ahnfelt-Ronne et al., 
2007; Esni et al., 2004). While this lateral inhibition model has remained essentially 
unchallenged for over a decade, recent reports have suggested alternatives and additional 
complexities to this model. 




Figure 1. Tip-trunk compartmentalization in the developing pancreas. Immunostaining of 
e14.5 epithelial chords in the mouse demonstrate that Ptf1a is predominantly restricted to the tips, 
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Ahnfelt-Ronne et al. provide data showing that Ptf1a is a transcriptional activator of Dll1 
expression in MPCs and that Hes1 is required for maintaining high levels of Ptf1a, suggesting 
that Hes1 acts upstream and downstream of Dll1. Additionally, the authors show that Notch may 
be subject to cis-inhibition by high levels of Dll1, which is induced by Ngn3 (Ahnfelt-Ronne et 
al., 2012). Another study illustrates a pro-endocrine role for Notch. Shih and colleagues show 
that, in addition to the Notch-mediated activation of Hes1 and subsequent repression of Ngn3, 
Notch is also responsible for the activation of Sox9, which is necessary for endocrine and ductal 
cell differentiation (Shih et al., 2012), establishing a novel pro-endocrine mechanism for Notch 
(that is, the opposite of its normal role in sustaining the undifferentiated progenitor condition). 
These studies clearly highlight the complex role of Notch signaling and warrant further 
investigations to explore at a cellular and carefully temporally resolved level the expression of 
the Notch family receptors and ligands.  
While a clear, mechanistic role for Notch-mediated regulation of Ngn3+ endocrine progenitors 
remains incondite, it is clear that Ngn3 is sufficient to promote endocrine development; when 
high levels of Ngn3 are expressed in early pancreas development, the entire pancreas develops 
into small clusters of glucagon-positive cells (Apelqvist et al., 1999; Johansson et al., 2007; 
Schwitzgebel et al., 2000). These studies clearly highlight the ‘trigger nature’ of Ngn3 in 
dictating the endocrine lineage; however, it had been unclear for years whether a single Ngn3 
positive cell has the capacity to generate any one of the five embryonic endocrine cell types, or if 
each Ngn3 positive cell has been previously specified to become a specific endocrine cell type.  
In order to address these issues, Desgraz et al. used clonal analysis by labeling single Ngn3+ 
endocrine precursors to illustrate that Ngn3+ cells are unipotent, meaning they can only give rise 
to one cell type (Desgraz and Herrera, 2009). Furthermore, the authors suggest that Ngn3+ 
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endocrine precursors may be pre-committed to a particular endocrine cell fate, given that Nkx6.1 
expression is required before Ngn3 expression for the acquisition of the beta-cell fate (Nelson et 
al., 2007). These findings raise another issue: if Nkx6.1 is required before the expression of 
Ngn3 for the differentiation along the beta-cell lineage, are there endocrine-cell-specific niches 
in the trunk domains at the onset of the second wave of endocrine cell formation? One could 
imagine the possibility that, prior to Ngn3 expression, the presence or absence, or the correct 
combination of transcription factors could generate a gene regulatory network that is responsible 
for initiating a particular endocrine cell lineage. These gene regulatory networks, while being 
specific to a particular endocrine cell lineage in each niche, would all be sufficient to activate 
Ngn3 expression. The obvious question then is: what would be the spatiotemporal signals that 
would provide instructive or permissive cues for the proper allocation of the correct set of 
transcription factors that would create the necessary gene regulatory network? One study has 
begun to answer this question by providing evidence that the temporal context within which the 
Ngn3+ cells arise governs the endocrine cell fate. Johansson et al. used Ngn3 null mice and added 
back Ngn3 function via a tamoxifen-inducible Ngn3 fusion transgenic approach to add back 
Ngn3 at various time points of pancreatic development using an inducible Pdx1 promoter 
(Johansson et al., 2007). The authors demonstrated that the early endocrine precursors (e8.75) 
are sufficient to produce alpha cells, whereas endocrine precursors do not acquire competence to 
develop beta cells until e11.5, with beta-cell formation peaking at e14.5. The authors further 
illustrated that Ngn3+ cells gained competence to produce PP and delta cells at e12.5 and e14.5, 
respectively. While this study heightens our understanding of the temporal regulation of 
endocrine lineage commitment, a detailed, comprehensive map of transcription factor expression 
in pre-committed endocrine cells is lacking. Having such a map would, potentially, enable us to 
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dissect mechanisms controlling MPC allocation, tip-trunk compartmentalization and endocrine 
cell commitment, and therefore, may facilitate how we approach stem cell differentiation 
protocols.  
Islet transcription factors 
There is a complex array of transcription factors that controls islet-cell-type lineage decisions. 
These transcription factors can generally be categorized into four groups based on their null 
phenotype. The first group, including Islet1 and NeuroD, affects all endocrine cells, causing 
either a complete loss or reduction of all islet cell types. Group two consists of Nkx2.2, Pax4 and 
Pax6 and affects most endocrine cells. The third group, comprising Arx, Nkx6.1 and Hlxb9, 
affects only one endocrine cell type, while the last group, including MafA, affects postnatal 
endocrine cell function (Table 1). This is not an exhaustive list, and there are many 
comprehensive reviews covering the pancreatic transcription factor gamut (Gittes, 2009; Oliver-
Krasinski and Stoffers, 2008; Pan and Wright, 2011). For the purpose of this thesis, I will focus 
on two important regulatory factors, Nkx2.2 and Arx.   
Nkx2.2         
Nkx2.2 is a member of the NK family of homeodomain proteins (originally identified in 
Drosophila (Kim and Nirenberg, 1989)) and, like many pancreatic transcription factors, was first 
identified for its role in neuronal differentiation (Price et al., 1992). Cloning strategies later 
revealed the expression of Nkx2.2 in multiple alpha and beta cell lines (Rudnick et al., 1994), 
and this was confirmed in the first in vivo analysis of Nkx2.2 in the developing pancreas (Sussel 
et al., 1998). It was demonstrated that Nkx2.2 is expressed as early as e9.5 and is present in alpha, 
beta and PP cells, but excluded from delta cells. Furthermore, Sussel and colleagues 
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demonstrated that a null mutation for Nkx2.2 results in hyperglycemia and lethality shortly after 
birth. Closer inspection of the pancreas revealed that Nkx2.2 mutant mice have a complete 
absence of beta cells and a severe reduction in alpha and PP cells. It was also noted that the 
mutant mice retain a large population of cells with endocrine characteristics, but lack mature 
markers of beta cells. At that time, the authors attributed this phenotype to the arrested 
development of beta cells; that is, Nkx2.2 is not required for the specification of beta cells, but is 
necessary for the differentiation and maturation of insulin expressing beta cells. That fact that 
some alpha and PP cells remained suggested that another factor could possibly compensate for 
Nkx2.2 in the development of these cells (Sussel et al., 1998). Later studies showed that this 
interpretation was incorrect, and that the absence of Nkx2.2 causes endocrine progenitors to 
become diverted from the beta cell fate to a newly identified epsilon cell, characterized by the 
expression of the hormone ghrelin (Prado et al., 2004). These ghrelin-positive cells, which are 
normally present in the gastric pits of the stomach (Kojima et al., 2001), were shown to be highly 
upregulated and in place of the beta cells in the Nkx2.2 null mouse. Remarkably, ghrelin was 
also shown to be transiently present, albeit in small numbers, in the normal embryonic mouse 
islet, defining a new pancreatic islet cell type. These data point to a role for Nkx2.2 in specifying 
and maintaining the beta cell lineage while suppressing the epsilon cell lineage.  
Doyle et al. extended these findings by determining whether Nkx2.2 is acting as a transcriptional 
activator or repressor during pancreas development. The creation of an Nkx2.2-engrailed fusion 
repressor or Nkx2.2-VP16 fusion activator construct expressed under the control of the Pdx1 
promoter in the Nkx2.2 null background demonstrated that Nkx2.2 repressor activity was 
sufficient for alpha cell differentiation, while repressing the epsilon cell lineage (Doyle et al., 
2007). Although some beta cells were rescued with Nkx2.2 repressor activity, these cells lacked 
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mature markers of bona fide, glucose-sensing beta cells, i.e., MafA and Glut2. This finding may 
reflect the requirement of Nkx2.2 transcriptional activator functions for the beta cell maturation 
process, which would be consistent with previous data illustrating Nkx2.2 as a transcriptional 
activator of MafA (Raum et al., 2006). Alternatively, the incomplete rescue of beta cells could be 
attributed to the lack of Nkx2.2 protein regulatory domains in the repressor derivative transgene; 
the Nkx2.2-engrailed fusion repressor transgene contained only the Nkx2.2 homeodomain fused 
to the engrailed repressor domain. The authors attempted to address this issue by expressing the 
full-length Nkx2.2 cDNA from the Pdx1 promoter, but were unable to establish any transgenic 
lines. The full rescue of the alpha-cell population is quite intriguing in that Pdx1, which was used 
to drive the Nkx2.2 repressor derivative, is strongly downregulated in in the normal development 
alpha cells. This suggests that Nkx2.2 repressor activity is only needed in the early Pdx1+ 
progenitor population to establish the alpha cell differentiation program.   
In the developing CNS, Nkx2.2 functions as a repressor by way of its interaction with the co-
repressor Groucho 4 (Grg4) (Muhr et al., 2001), and given that the Nkx2.2 seems, at least 
partially, to function as a repressor in the developing islet, Doyle et al. investigated the 
expression of Grg family members during pancreas organogenesis. Grg4 expression was 
undetectable in the pancreatic epithelium. In contrast, Grg1 and 2 were expressed at low levels, 
while Grg3 had the highest expression. RNA in situ analyses further determined that Nkx2.2 and 
Grg3 had similar expression patterns in early (e12.5) and late (e16.5) pancreas development, and 
a combination of RNA in situ hybridization and immunodetection revealed that the Grg3 
expression domain overlapped with the endocrine compartment and was excluded from the 
exocrine pancreas. Additional biochemical studies showed that Nkx2.2 was able to physically 
interact with Grg3, and this interaction required the N-terminal decapeptide TN domain, 
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previuolsy shown essential for the Grg4 interaction in neural cells (Doyle et al., 2007; Muhr et 
al., 2001). Doyle and Sussel expanded these findings by expressing the Nkx2.2 repressor 
derivative in the adult beta cell, which resulted in the loss of MafA and Glut2 expression, as well 
as endogenous Nkx2.2 (Doyle and Sussel, 2007), suggesting a self-regulating and activating 
function. These reports provide a great example of the diverse roles that a transcription factor can 
play at various times and in different cellular contexts during development. While these studies 
have improved our understanding of the molecular mechanism underlying Nkx2.2 function in the 
endocrine cell ontogeny, there are caveats worth noting. The Pdx1 promoter, which is expressed 
in a similar but not identical spatiotemporal domain to Nkx2.2,, was used to drive the expression 
of the transgenes. In addition, only the Nkx2.2 homeodomain was present in the transgenes. This 
could potentially disrupt the interaction with co-regulators that interact with Nkx2.2 through 
well-conserved regulatory protein domains, such as the NK2-SD domain, the defining domain of 
the Nkx2 family of transcription factors. However, the fact that the Nkx2.2 repressor derivative 
can partially restore islet cell differentiation, and especially cause a full rescue of alpha cells, 
indicates that it has at least some capacity to replace normal endogenous functions, which begets 
the question: when, and in which cell, and on which genes is Nkx2.2 repressor activity required?  
To help answer these questions, a major focus of this dissertation is to define the exact role of 
Grg-mediated Nkx2.2 repression during mouse pancreatic development.    
Arx 
Another transcription factor required for specific endocrine cell lineage is Arista-less homeobox 
(ARX) gene. Mice carrying a null mutation for Arx exhibit a complete loss of mature alpha cells 
with a corresponding increase in the beta and delta-cell populations, so that the total endocrine 
cell count is unaltered. This shift in cell fate seems to be due to unopposed Pax4 expression, 
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which is required for beta-cell specification (Collombat et al., 2005; Collombat et al., 2003). 
Consistent with these findings, the overexpression of Arx in Pdx1+ progenitor cells was sufficient 
to shunt most beta and delta cells toward the alpha and PP cell lineages. This divergence from 
beta cells to alpha or PP cells can be recapitulated when Arx is overexpressed specifically in beta 
cells using Ins:Cre. Finally, when Arx is overexpressed in four-week-old mice using an inducible 
Pdx1:CreER, which is restricted to beta cells at this time, Arx is adequate to reprogram the beta 
cell to either an alpha or PP cell (Collombat et al., 2007). A closer, molecular analysis of Arx 
regulation revealed an epigenetic component involving DNA methylation of the Arx promoter 
that is required for its repression specifically in beta cells. In this study, beta cells deficient for 
the maintenance DNA methyltransferase, Dnmt1, were directly reprogrammed to alpha cells. The 
Arx promoter was shown to be normally hypermethylated in beta cells, preventing its expression, 
while being hypomethylated in alpha cells. Upon deletion of Dnmt1 specifically in beta cells, the 
Arx promoter lost the methylated signature, expression was de-repressed and an alpha-to-beta 
cell conversion ensued (Dhawan et al., 2011). This is consistent with the previous studies that 
report Arx is sufficient to divert the beta-cell lineage to the alpha-cell lineage, and ectopic 
expression of Arx can reprogram beta cells to alpha cells. A greater discussion about the 
regulation of the Arx promoter, and its relationship with Nkx2.2, will be presented in chapter 2.   
The phenotypes of the Arx null mice and Nkx2.2 null mice share a common thread; they both 
have either a severe or total loss of alpha cells, and recent reports have described genetic 
interactions between Arx and Nkx2.2. Despite a severe reduction in alpha cells in the Nkx2.2 null 
mice, the expression of Arx is unchanged (Chao et al., 2007). Mastracci et al. have confirmed 
this finding and demonstrated that Arx was localized to the ghrelin cells that become massively 
increased in number in the absence of Nkx2.2. Interestingly, the compound Nkx2.2/Arx double 
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mutant (in this case, Arx was deleted specifically in the pancreas) revealed that Arx is necessary 
for ghrelin expression but not Ghrelin cell specification. The double mutant mouse had the 
expected increase in ghrelin+ cells, which was not statistically different from Nkx2.2 null mice; 
however, ghrelin expression was significantly decreased. Immunofluorescent detection of 
ghrelin in double-mutant mice displayed a much weaker signal compared to Nkx2.2 null mice. 
Since the ghrelin signal was not decreased in Arx single mutants compared to wild-type mice, the 
authors suggested that Arx may only be able to regulate ghrelin expression in the absence of 
Nkx2.2 (Mastracci et al., 2011). The inverse was shown for delta cell and somatostatin 
expression. As previously mentioned, Arx deletion results in an increase in delta cells and 
somatostatin expression. In the Nkx2.2/Arx double mutant the increase in delta cells persists, yet 
somatostatin expression increases nearly 3-fold. This phenomenon was attributed to 
Ghrelin/Somatostatin co-positive cells that arise as early as e12.5 in the Nkx2.2/Arx double 
mutant, but are undetectable in the wild type and Nkx2.2 null mice (Mastracci et al., 2011). The 
finding that Nkx2.2/Arx compound deficiency leads to ghrelin/somatostatin co-positive cells was 
independently confirmed (Kordowich et al., 2011). These studies merit further investigations to 
dissect the molecular components that regulate the crosstalk between these transcription factors 
that governs early endocrine cell specification and lineage commitment.   
Groucho proteins 
The Drosophila groucho (gro) gene was first identified from a viable mutation resulting in 
clumps of supernumerary bristles above the eye, a characteristic reminiscent of Groucho Marx. 
The gro protein is the prototype of a family of co-repressors known as Transducin-like enhancer 
of split (TLE) 1-4 in humans, and groucho-related gene (Grg) 1-4 in mice. (Hereafter, I will be 
referring to groucho proteins, in general, using the mouse nomenclature, Grg). Grg proteins are 
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broadly expressed and are recruited to DNA by interacting with a diverse group of transcription 
factors. Correspondingly, many developmental phenotypes are compromised in the loss of Gro 
in the fly (Delidakis et al., 1991; Paroush et al., 1994), while embryonic lethality occurs in the 
mouse (Metzger et al., 2012). Structural studies have determined that the WD-repeat (WDR) 
domain at the C-terminus of Grg acts as the protein interaction interface for most transcription 
factors. The WDR domain interacts with one of two short polypeptide motifs: 1) WRPW and 
related tetrapeptide motifs and 2) engrailed homology 1 (eh1) domains (Fisher et al., 1996; 
Goldstein et al., 2005; Jimenez et al., 1997; Muhr et al., 2001; Paroush et al., 1994). Because of 
its ability to interact with an array of transcription factors containing these peptide motifs, as well 
as other proteins harboring different peptide sequences (Aronson et al., 1997; Daniels and Weis, 
2005), Grg is involved in many developmental signaling pathways, including Notch and WNT.  
The most notable effecters of Notch signaling are the bHLH factors of the Hes family (Bray, 
2006), factors for which Grgs have been shown to act as co-repressors (Ju et al., 2004; Nuthall et 
al., 2004). In Drosophila, Gro was shown to operate at a functional intersection between the 
Notch and EGF signaling pathways. Specifically, in response to Notch signaling, Gro 
antagonizes vein formation and bristle patterning through Hes-mediated repression, and Hasson 
et al. demonstrated that EGFR-mediated Gro phosphorylation by MAPK is sufficient to relieve 
the Gro/Hes-mediated repression of downstream Notch targets, allowing for proper vein 
formation and bristle patterning (Hasson et al., 2005).  
WNT signaling has a well appreciated role in patterning and cell determination events (Logan 
and Nusse, 2004). The central player in canonical WNT signaling is beta-catenin, a co-activator 
for Tcf/Lef factors. In the absence of WNT signaling, cytoplasmic beta-catenin is phosphorylated, 
marking it for proteolysis. Conversely, active WNT signaling inhibits the destruction of beta-
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catenin, leading to its cytoplasmic accumulation and translocation to the nucleus, where it binds 
to Tcf/Lef factors, activating downstream target genes (Clevers, 2006).  Interestingly, in the 
absence of WNT signaling, Tcf/Lef factors recruit Grgs to repress target genes (Barolo and 
Posakony, 2002). Correspondingly, Grg deficiencies in both Drosophila and vertebrates manifest 
phenotypes similar to that of WNT signaling overexpression (Cavallo et al., 1998; Roose and 
Clevers, 1999).  
Mechanisms of repression 
Several mechanistic models of Grg-mediated repression have evolved, one of which is the well-
characterized histone deacetylase (HDAC) recruitment (Arce et al., 2009; Chen and Courey, 
2000; Watson et al., 2000; Winkler et al., 2010). However, HDAC recruitment and histone 
deacetylation cannot be the only mechanism by which Grgs repress gene expression, as shown 
by deletion mutants (Fisher et al., 1996), deacetylase inhibitors (Yao et al., 2001), and anti-
HDAC antibodies (Dasen et al., 2001). In the context of WNT signaling, it has been determined 
that Grg can out-compete beta-catenin for Tcf/Lef binding and vice versa. Therefore, high levels 
of WNT activity, and consequently beta-catenin accumulation, will out-compete Grg for Tcf/Lef 
binding, relieving repression. Thus, the level of WNT activity will dictate the binding partner of 
Tcf/Lef, leading to either repression (which in this case is the displacement of co-activators) or 
activation (Daniels and Weis, 2005). Another study determined that phosphorylation of the 
paired-box transcription factor Pax2 by c-Jun N-terminal kinase (JNK), a modification that 
enhances Pax2-dependent transcription, is inhibited by its interaction with Grg4, causing Pax2-
dependent repression (Cai et al., 2003). This group expanded on these findings to show that the 
recruitment of Grg4 to Pax2 DNA binding sites is sufficient to displace an H3K27me complex 
(an epigenetic mark of active chromatin, discussed later in this chapter) and to subsequently 
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recruit the arginine methyltransferase PRMT5, an enzyme responsible for H4R3 dimethylation 
and recruitment of Polycomb proteins (Patel et al., 2012). Another mechanism of repression 
involves the targeted recruitment of Grg by DNA-binding proteins, and the subsequent 
oligomerization of Grg, spanning three to four nucleosomes. In this scenario, Grg both condenses 
the chromatin and forms aggregates, thereby preventing activator recruitment and repressing 
transcription (Sekiya and Zaret, 2007). While Grg proteins have a well-appreciated repressor 
function, it is important to keep in mind that Grg has also been shown in certain contexts to act 
as a co-activator (Villanueva et al., 2011). Grg3 was shown to integrate the PPARγ and Wnt 
pathways in adipogenesis by acting as a co-activator of PPARγ target genes, while antagonizing 
Wnt signaling. These findings suggest that Grg may not be functioning as a co-repressor in all 
contexts, and its role as a repressor or activator may depend on cell- or promoter-specific binding 
partners.   
Role in pancreas development 
Grg has been well characterized in neuronal development and differentiation (Gasperowicz and 
Otto, 2005); however, very little is know about its role in pancreas development. The first paper 
ascribing a role for Grg in proper pancreatic endocrine formation was from Doyle and colleagues, 
who reported that Grg1, 2 and 3 were expressed in the developing pancreas (Doyle et al., 2007). 
The authors further determined that Grg3 exhibited a similar expression profile to Nkx2.2 and, 
through co-immunoprecipitation analyses, demonstrated that Nkx2.2 and Grg3 physically 
interact. These findings were extrapolated to attribute the mechanism by which Nkx2.2 repressor 
function can partially rescue the Nkx2.2 null phenotype. A more recent study attempted to 
investigate Grg function during pancreas development by analyzing the pancreas defects in a 
Grg3 null condition. Since the non-tissue-specific loss of Grg3 results in embryonic lethality by 
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e14.5, possibly due to placental defects, Metzger et al. used e12.5 pancreatic explants to dissect 
roles for Grg3 ex vivo (Metzger et al., 2012). Their findings highlighted a role for Grg3 in proper 
delamination of endocrine precursors from the trunk epithelium. Consequently, a reduction in all 
endocrine cell types was observed, because of the loss of Grg3-mediated E-cadherin 
downregulation, which is a de-adhesion step apparently critical for the proendocrine cell 
delamination from the trunk epithelium (Gouzi et al., 2011). While this study provides evidence 
of a role for Grg3 in pancreas development, the experimental methods make it difficult to ascribe 
specific roles for Grg3, i.e., Grgs interact with many factors, and by using a knock out model, the 
function of multiple Grg-interacting regulatory factors may potentially be disrupted. Secondly, 
the embryonic lethality caused by the global Grg3 inactivation constrains the investigators to an 
ex vivo approach, which may be significantly different and confounding as compared to a fully in 
vivo analysis.Nevertheless, these studies provide data that warrant more elegant explorations into 
deciphering roles for Grg proteins in pancreas development.  
Transcriptional regulation 
Genes need to be regulated in a context-dependent manner for proper cell fate determination. 
Many years of study have yielded the unequivocal conclusion that gene repression is as 
influential as activation mechanisms; indeed, repression might be the predominant mode of 
transcriptional modulation, especially for tuning levels and timing of gene expression to 
sophisticated cell differentiation programs..Fundamental potent controllers of the activated or 
repressed state include DNA methylation (Suzuki and Bird, 2008), histone modifications (Wang 
et al., 2004) and chromatin remodeling (Ho and Crabtree, 2010). Understanding how these 
processes control gene regulation in cell-type-specific and developmental-stage-specific contexts 
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is essential to comprehend the underlying processes controlling pancreatic cell type 
differentiation.  
Repression mechanisms controlling pancreas development 
Developmental processes, including cell specification, are often controlled by the spatial 
expression of gene activity, during which boundaries of gene expression are determined by the 
restricted activity of transcriptional repressors. In the pancreas, evidence exists for a cross-
repressive mechanism controlling the tip-trunk compartmentalization (Haumaitre et al., 2005; 
Lynn et al., 2007; Schaffer et al., 2010), which demarcates the bi-potential ductal/endocrine 
progenitors from the acinar progenitors. Similar scenarios exists in other systems, such as the 
CNS, where cross-repressive interactions between homeodomain proteins refine and maintain 
progenitor domains (Briscoe et al., 2000). Repression mechanisms are also used to distinguish 
one organ anlage from another, which is the case for ventral foregut endoderm, as it undergoes a 
fate choice between liver or ventral pancreas progenitors. Xu et al. determined that H3K27me3 
and the PcG protein, Ezh2, were enriched on the Pdx1 enhancer elements in early endodermal 
cells, and these features were absent from liver regulatory elements. Inducing the loss of Ezh2 
from within the early endoderm results in an expanded Pdx1+ ventral pancreatic domain. This 
expansion occurrs at the expense of liver development, and the result suggests Ezh2 acts 
permissively to allow liver development by restraining ventral pancreas development (Xu et al., 
2011). As pancreatic development proceeds, proper beta-cell-lineage commitment requires the 
repression of non-beta-cell factors; aberrant expression of non-beta-cell factors, such as Arx, 
diverts the beta-cell lineage to an alpha/PP lineage (Collombat et al., 2005; Collombat et al., 
2003). More recently, molecular studies analyzing the Arx promoter revealed an integrated 
mechanism controlling Arx repression in beta cells (Dhawan et al., 2011). DNA methylation is 
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required to correctly repress Arx in beta cells and to maintain their identity. This methylation was 
not observed on the Arx promoter in alpha cells, which is the cell type within which it is 
normally expressed as an alpha-cell specification factor. Arx promoter methylation recruits the 
methyl-binding protein, MeCP2, which recruits PRMT6, leading to H3R2 methylation and 
repression. The beta-cell-specific deletion of Dnmt1 led to the gradual loss of Arx promoter 
methylation, and its subsequent de-repression, which was sufficient to reprogram the beta cell to 
an alpha cell. The phenotype exhibited by beta-cell-specific loss of Dnmt1 was not immediate, 
but gradual, caused by the property of Dnmt1 being required for maintaining methylation only 
after cell division occurs, and normal beta cells replicate at an extremely low rate (Teta et al., 
2005). However, this work shows the importance of properly inherited patterns of repression of 
alpha-cell lineage determination factors for normal development and maintenance of beta cells.  
The observed decrease in beta-cell replication with advancing age (in both mice and humans) is 
another process controlled by repressive mechanisms. Normal beta-cell replication is required for 
proper islet size, maintaining homeostasis and for adapting islet function in the face of metabolic 
demand, such as diet fluctuation, pregnancy, and others (Dor et al., 2004; Kulkarni et al., 2004; 
Okamoto et al., 2006; Zhong et al., 2007). Normal healthy mice show a precipitous drop in the 
number of replicating beta cells occurring just after birth, and this number steadily declines in 
advancing age (Teta et al., 2005). In young animals, p16/Ink4a is repressed in beta cells by the 
presence of Bmi-1 and Ezh2-induced H3K27me3. With advancing age, the H3K27me3 mark and 
the Bmi-1 chromatin regulatory protein are replaced with H3K4me3 and MLL1, allowing for 
p16/Ink4a de-repression. p16 is a cyclin-dependent kinase inhibitor and a negative regulator of 
the cell cycle. Thus, the de-repression of p16/Ink4a in the beta cell inhibits beta-cell proliferation. 
It has also been illustrated that the beta-cell-specific deletion of Ezh2 led to a precocious 
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decrease in beta cell replication. Furthermore, the regeneration and replication of beta cells 
following STZ-induced beta-cell destruction was mediated by an upregulation of Ezh2 and 
subsequent repression of p16/Ink4a, which was not observed in beta-cell-specific Ezh2 null mice 
(Chen et al., 2009a; Dhawan et al., 2009). These data highlight that gene repression is as 
important as gene activation in the correct specification, development and maintenance of 
pancreatic beta cells. 
Post-transcriptional modification  
Many transcription factors carry out the complex task of differentially regulating multiple genes; 
within a cell, a transcription factor may aid in repressing one gene while activating another. In 
Drosophila neural stem cells, Prospero (Prox1 in vertebrates) has been shown to repress genes 
required for self-renewal and activate genes necessary for differentiation (Choksi et al., 2006). 
Often times this “binary switch” involves differential recruitment of cofactors. But how does a 
transcription factor choose to interact with, for example, a co-repressor on gene A and a co-
activator on gene B, when all three are coexpressed in the same cell? Another interesting 
scenario is the ability of a transcription factor to repress a gene in a progenitor cell, but then 
activate the same gene as the cell differentiates.  
Many studies have demonstrated that post-translational modification (PTM) of transcription 
factors can directly flip a protein between activator and repressor functions, perhaps driving 
acute switching between potent coactivators/corepressors. c-Myc PTMs that influence its 
functional activities have been especially well characterized (Luscher and Vervoorts, 2012). 
Recently, Uribesalgo et al. provided a mechanism by which c-Myc phosphorylation mediates 
whether retinoic acid receptor α (RARα) represses or activates its target genes (Uribesalgo et al., 
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2011). In the absence of retinoic acid (RA), RARs associate with co-repressors and constitutively 
repress target genes. Upon stimulation with RA, a conformational change occurs in the RAR and 
co-repressors are exchanged for co-activators, resulting in gene transcription. Uribesalgo et al. 
show that c-Myc regulates RA-response element (RARE)-containing genes by binding to RARα. 
The co-repressors HDAC3 and N-CoR were associated with RARα and enriched at RAREs in 
the presence of dephosphorylated c-Myc. Conversely, constitutively phosphorylated c-Myc, even 
in the absence of RA, disrupts c-Myc binding to RARα and causes an exchange in the co-
repressor complex for the histone acetyltransferase CBP leading to increased histone acetylation 
and gene activation. 
 Another phenomenon is the ability of a transcription factor to switch between repressor and 
activator modes over time as a cell moves through ontogeny. Ju et al. used an in vitro system to 
analyze the regulation of Mash1 in neural differentiation and illustrate how Hes1 changes from 
repressing to activating Mash1. Treatment of neural stem cells with PDGF initiates development 
along a neural pathway, which is characterized by the expression of Mash1. Repression of the 
Mash1 promoter is maintained in neural stem cells by a Hes1/Parp1/TLE1 complex, but within 
hours of PDGF treatment, Mash1 expression is de-repressed, and co-repressors are exchanged 
for co-activators; however, Hes1 and Parp1 remained. PDGF treatment also stimulates 
expression of CaMKIIδ, which was shown to phosphorylate Parp1 and Hes1. This 
phosphorylation is necessary for the exchange of cofactors; loss of CaMKIIδ resulted in stable 
repression of Mash1 even in the presence of PDGF (Ju et al., 2004).  
Many other transcription factors have been shown to differentially regulate gene expression in 
response to PTM. For example, protein kinase A phosphorylation of NF-κB creates CBP/p300 
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binding sites, leading to NF-κB target gene activation (Zhong et al., 1998), and Pax2 
phosphorylation by c-Jun N-terminal kinase precludes binding with Grg, allowing for Pax2-
dependent transactivation (Cai et al., 2003). However, very little is known about PTM of 
pancreatic factors and how they might contribute to gene regulation in pancreas development. 
Multiple groups have demonstrated that Pdx1 contains several different PTMs, including 
phosphorylation, glycosylation and sumoylation (Boucher et al., 2006; Elrick and Docherty, 
2001; Gao et al., 2003; Kishi et al., 2003), some of which are responsible for selective 
interactions with cofactors (Mosley et al., 2004; Mosley and Ozcan, 2004) Most recently, Frogne 
et al. provided convincing evidence that the majority of Pdx1 phosphorylation is occurs at serine 
61 (S61) (Frogne et al., 2012). While this study did not determine a function for S61 
phosphorylation, it was demonstrated, in contrast to other studies of Pdx1 PTM, that S61 
phosphorylation was not regulated by glucose. Another pancreatic factor, NeuroD, can also be 
phosphorylated, and this PTM was demonstrated to regulate NeuroD in a context-dependent 
manner. In Xenopus over-expression gain-of-function experiments, the S266A and S274A 
mutations in NeuroD, which mimic dephosphorylation, act as strong activators of multiple 
neuronal program genes, and greatly increase ectopic neurogenesis (Dufton et al., 2005). But 
these same alterations cause and inhibitory effect, compared to wild-type NeuroD, in a 
pancreatic beta cell line (Khoo et al., 2003b).  
Collectively, these studies illustrate the importance of transcription factor PTM. Despite the large 
amount of collective work over the last 20 years on unraveling the transcriptional cascades of 
endocrine lineage allocation, it is surprising that so little attention has been focused on such a 
potent functional influence. PTM can modulate many aspects of protein function, including 
cofactor interactions, cytoplasmic/nuclear shuttling, DNA binding, and protein turnover.  
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The overall goal of my Ph.D. thesis research was to define regulatory domains within the Nkx2.2 
protein and possible PTMs that contribute to its apparent variation (amongst cell types and over 
time) of functions, specifically focusing on the idea that there could be a large degree of back-
and-forth activator-repressor switching. I began by analyzing mice with a knock-in mutation of 
the Nkx2.2-TN domain. This domain contains homology to the core eh1 region of the Engrailed 
repressor and has previously been characterized as essential for interaction with Grg proteins in 
the CNS (Muhr et al., 2001). Our lab has previously shown that Nkx2.2 repressor activity can 
partially rescue the Nkx2.2-null phenotype, and since Grg3 was shown to be expressed in the 
endocrine pancreas and interact with Nkx2.2, we predicted that by mutating the Nkx2.2-TN 
domain, we would disrupt the interaction with Grg3, and therefore, the role of Grg-mediated 
Nkx2.2 repression in pancreas development could be defined. This is a practical and elegant 
approach, as opposed to a pancreas- or beta-cell-specific loss of Grg, which would demonstrate a 
more global role for Grgs in the pancreas. Instead, we are trying to define precise, Grg-mediated 
Nkx2.2 functions.  
My careful phenotypic analyses led to the determination that mice carrying a homozygous TN 
mutation (Nkx2.2TNmut/TNmut) have aberrant islet hormone expression beginning at e13.5, 
characterized with an increase in ghrelin expression and a slight decrease in insulin expression. 
As the embryos developed, this phenotype worsened, and by e18.5 glucagon expression and 
alpha-cell numbers were significantly increased. The expression of cell-type-specific 
transcription factors paralleled these changes, with decreases in beta-cell factors and increases in 
alpha-cell factors. However, Arx, and alpha-cell lineage determinant, was significantly elevated 
before increases in alpha cells or increases in glucagon expression were observed. I discovered 
that Arx was ectopically expressed in beta cells, which suggested Grg-mediated Nkx2.2 
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regulation was necessary for beta-cell-specific repression of Arx. Moving to a more molecular 
level, I used cell lines to determine that Nkx2.2 is present in a repressor complex on the 
methylated Arx promoter specifically in beta cells, but this complex was absent in alpha cells. I 
further demonstrated that the ectopic expression of Arx in Nkx2.2TNmut/TNmut mice was necessary 
to reprogram the beta cells to alpha cells, and this reprogramming occurred both embryonically 
and postnatally. Since beta-cell-specific loss of Arx in the Nkx2.2TNmut/TNmut mice rescued the 
beta-cell reprogramming, I concluded that the ectopic expression of Arx was solely responsible 
for the beta-to-alpha transdifferentiation. However, beta-cell-specific deletion of Arx was not 
sufficient to rescue lineage specification defects in Nkx2.2TNmut/TNmut mice, and these adult mice 
remained hyperglycemic. Interestingly, the Nkx2.2TNmut/TNmut mice do not have an early 
phenotype as is seen in the Nkx2.2-null mice. These findings illustrate the importance of the 
spatiotemporal regulation of lineage commitment decisions by cofactors and highlight a role for 
epigenetic and transcription factor interactions for proper gene regulation.  
To determine if PTMs affect Nkx2.2 function, I began by examining the Nkx2.2 peptide 
sequence for putative PTM sites. In silico analysis revealed several serine and lysine residues 
that were predicted to be phosphorylated and acetylated, respectively. Mutation of these residues 
affected Nkx2.2 target gene expression in vitro, most likely by an inability of Nkx2.2 to properly 
recruit cofactors to target genes. These data warrant further investigations of Nkx2.2 PTM and 
the effect on its highly flexible transcriptional regulatory properties. 
Collectively, my thesis studies have provided insight into how regulatory domains and PTMs 
contribute to Nkx2.2 function. Further understanding the molecular events that mediate 
transcription factor function in spatiotemporal regulation of pancreas development will aid our 
protocols to induce beta cells from alternate sources.  
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CHAPTER 2 
PUBLISHED MANUSCRIPT: NKX2.2 REPRESSOR COMPLEX REGULATES ISLET 
β-CELL SPECIFICATION AND PREVENTS β-TO-α-CELL REPROGRAMMING 
James Papizan generated all data presented in this chapter except for the data included in Figures 
5B,C,E, F; Supplemental Figure 7B (S. Tschen, S. Dhawan, A. Bhushan), Figure 3A-C; and 
Supplemental Figures 1D-J; 2E-H (R. Singer). R. Singer generated the Arx-pGL3 vector, J.M. 
Friel created the Nkx2.2TNmut construct, and members from the M. Magnuson laboratory 















Nkx2.2 repressor complex regulates islet
b-cell specification and prevents
b-to-a-cell reprogramming
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Regulation of cell differentiation programs requires complex interactions between transcriptional and epigenetic
networks. Elucidating the principal molecular events responsible for the establishment and maintenance of cell
fate identities will provide important insights into how cell lineages are specified and maintained and will improve
our ability to recapitulate cell differentiation events in vitro. In this study, we demonstrate that Nkx2.2 is part of
a large repression complex in pancreatic b cells that includes DNMT3a, Grg3, and HDAC1. Mutation of the
endogenous Nkx2.2 tinman (TN) domain in mice abolishes the interaction between Nkx2.2 and Grg3 and disrupts
b-cell specification. Furthermore, we demonstrate that Nkx2.2 preferentially recruits Grg3 and HDAC1 to the
methylated Aristaless homeobox gene (Arx) promoter in b cells. The Nkx2.2 TN mutation results in ectopic
expression of Arx in b cells, causing b-to-a-cell transdifferentiation. A corresponding b-cell-specific deletion of
DNMT3a is also sufficient to cause Arx-dependent b-to-a-cell reprogramming. Notably, subsequent removal of
Arx in the b cells of Nkx2.2TNmut/TNmut mutant mice reverts the b-to-a-cell conversion, indicating that the
repressor activities of Nkx2.2 on the methylated Arx promoter in b cells are the primary regulatory events
required for maintaining b-cell identity.
[Keywords: islet development; b-cell reprogramming; Nkx2.2; DNMT3a; transcriptional repression; DNA methylation]
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In the developing embryo, cell fates are achieved through
the regulated activation and repression of transcription
factors, which act as intermediaries in response to the
secretion of inductive signals. The acquisition of cell fate
is accomplished by a series of differentiation steps that
were once thought to be irreversible. More recently,
however, studies in multiple systems have demonstrated
that dedifferentiation and transdifferentiation are mech-
anisms commonly used during developmental programs
and in paradigms of regeneration (Tsonis et al. 2004;
Mirsky et al. 2008; Jopling et al. 2010, 2011). The ability
to reprogram somatic cells into pluripotent cells by the
expression of transcription factors has also demonstrated
the feasibility of direct reprogramming that does not
require an intermediate dedifferentiation step (Takahashi
and Yamanaka 2006; Boland et al. 2009). Following this
breakthrough, there have been many examples of tissue
reprogramming, including the transdifferentiation of fi-
broblasts into functional cardiomyocytes or multilineage
blood progenitors (Ieda et al. 2010; Selvaraj et al. 2010;
Szabo et al. 2010).
Similar to most other developmental systems, lineage
determination and cell specification in the developing
pancreas involve an organized series of events consisting
of appropriately timed extrinsic signaling that regulates
hierarchies of transcriptional networks (Gittes 2009). In
addition, recent studies have exploited the known islet
transcriptional networks to transdifferentiate nonpancre-
atic or exocrine tissue into endocrine cells. Ectopic
expression of different combinations of pancreatic tran-
scription factors—including Pdx1, Ngn3, NeuroD,MafA,
and Nkx6.1—promotes liver-to-pancreatic b-cell repro-
gramming (Chan et al. 2003; Kojima et al. 2003; Song et al.
2007; Delisle et al. 2009; Nagaya et al. 2009; Gefen-Halevi
et al. 2010). Similarly, ectopic expression of a defined set
of transcription factors in adult pancreatic acinar cells
results in an acinar-to-b-cell conversion (Zhou et al.
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2008). Recent studies have also demonstrated a previously
unappreciated plasticity between the different islet cell
types in embryonic and adult pancreas. Misexpression of
the a-cell-specific transcription factor Aristaless homeo-
box gene (Arx) in fetal b cells is sufficient to cause a b-to-
a-cell conversion (Collombat et al. 2007). Furthermore,
Thorel et al. (2010) have shown that mice with a >90%
reduction in b cells are able to replenish the lost b cells
through the up-regulation of b-cell factors in a cells to
induce a-to-b-cell transdifferentiation. Most recently,
epigenetic manipulations have also demonstrated the
importance of DNA methylation and histone modifica-
tions in maintaining b-cell identity and driving islet cell
differentiation (Haumaitre et al. 2009; Dhawan et al.
2011). These groundbreaking studies have underscored
the potential of using reprogramming methods to gener-
ate novel sources of islet cells.
The homeodomain transcription factor Nkx2.2 is re-
quired for cell fate decisions in the pancreatic islet and
cell patterning in the ventral neural tube (Sussel et al.
1998; Briscoe et al. 1999). It has previously been shown
that Nkx2.2 acts as a transcriptional repressor to regulate
ventral neural patterning through its interaction with the
corepressor Groucho-4 (Grg4) (Muhr et al. 2001). This
interaction is mediated by a motif called the tinman (TN)
domain, which shares sequence homology with the core
region of the engrailed homology-1 domain in the tran-
scriptional repressor Engrailed and through which Grg/
TLE proteins interact (Lints et al. 1993; Smith and Jaynes
1996; Jimenez et al. 1997). In the developing pancreas,
Nkx2.2 appears to function as either a transcriptional
repressor or an activator, depending on the temporal- or
cell-specific environment (Watada et al. 2000; Cissell
et al. 2003; Raum et al. 2006; Doyle and Sussel 2007;
Doyle et al. 2007; Anderson et al. 2009).
To further investigate the regulatory role of Nkx2.2 in
the developing pancreas and its dependence on Grg
interactions, we generated mice containing amino acid
substitutions in the highly conserved TN domain of the
endogenous Nkx2.2 gene (Nkx2.2TNmut/TNmut). In this
study, we demonstrate that the TN domain is required for
the in vivo interaction betweenNkx2.2 andGrg3 and that
the interaction with Grg proteins is required for two
independent stages of development. At embryonic day
13.5 (E13.5), during the initiation of the secondary
transition, the Nkx2.2 TN domain is necessary for the
b- versus e-cell fate decision. Subsequently, after b cells
have formed, the Nkx2.2 TN domain is essential for
maintaining b-cell identity through the repression of the
a-cell determinant Arx. In this analysis, we determined
that although Nkx2.2 is present in both a and b cells, it
preferentially binds the promoter of the a-cell-specific
factor Arx in b cells when the promoter is in a hyper-
methylated state. Furthermore, we demonstrate that
Nkx2.2 is present in a complex with the de novo
methyltransferase Dnmt3a and repressor cofactor Grg3.
In the b-cell context, Nkx2.2 preferentially recruits Grg3
and HDAC1 to the Arx promoter to repress Arx tran-
scription. Disruption of the interaction between Nkx2.2
and Grgs in mice leads to ectopic expression of Arx in b
cells and is sufficient to cause b-to-a-cell reprogramming
during embryonic development and in the adult. We
further show that by removing Arx specifically in the
Nkx2.2TNmut/TNmut b cells, the b-to-a-cell conversion
can be prevented. These combined in vitro and in vivo
studies elucidate how cell-specific DNA modifications
and transcriptional regulatory events come together to
establish and maintain islet b-cell identity.
Results
Mutation of the Nkx2.2 TN domain disrupts
the in vivo interaction between Nkx2.2
and the Grg3 corepressor and leads to diabetes
in adult Nkx2.2TNmut/TNmut mice
In the pancreas, Grg2 and Grg3 are coexpressed with
Nkx2.2 (Doyle et al. 2007; Hoffman et al. 2008), and Grg3
interacts with Nkx2.2 via the conserved TN domain
(Doyle et al. 2007). To determine whether the physical
interaction between Nkx2.2 and Grg proteins is neces-
sary for appropriate pancreatic islet development and/or
function, we generated mice that express a mutant allele
of Nkx2.2 containing amino acid substitutions within the
core sequence of the TN domain (Nkx2.2TNmut/TNmut)
(Fig. 1A). Presence of the mutant allele was monitored
using allele-specific primers (Fig. 1B; Materials and
Methods). Heterozygous Nkx2.2TNmut/+ and homozygous
Nkx2.2TNmut/TNmut mice display grossly normal pancre-
atic morphology and histology at birth (Fig. 1C,D; data
not shown). Importantly, mutation of the TN domain
does not appear to affect Nkx2.2 mRNA or protein
stability in Nkx2.2TNmut/+ and Nkx2.2TNmut/TNmut mice
(Fig. 1E,F; data not shown); however, we confirmed that
mutation of the TN domain is sufficient to abolish the
endogenous Nkx2.2–Grg3 interaction (Fig. 1G). The
Nkx2.2TNmut/TNmut mice survive postnatally, but the
male mice begin to display overt hyperglycemia by 3.5
wk of age (Supplemental Fig. 1A,B). By 6 wk, both male
and female Nkx2.2TNmut/TNmut mice are severely diabetic
in fed and fasted conditions, with compromised fertility
(Fig. 2A; Supplemental Fig. 1C). The Nkx2.2TNmut/TNmut
mice do not survive beyond 8 wk of age. Histological
analysis of the 6-wk-old Nkx2.2TNmut/TNmut pancreas
indicates that total islet cell numbers are unchanged,
but the mutant islets are smaller and more disorganized
than in wild-type littermate controls (Fig. 2B,C,F). Con-
sistent with the phenotype of the Nkx2.2!/!mice, which
form fewer a and no b cells, the Nkx2.2TNmut/TNmut islets
have fewer insulin-producing b cells (Fig. 2D). Surpris-
ingly, however, the number of glucagon-producing a cells
appears to be increased (Fig. 2E). The Nkx2.2TNmut/TNmut
mice do not display any apparent defects in d-, pancreatic
polypeptide (PP), or acinar cell populations (data not shown).
Nkx2.2 TN domain is required for appropriate islet
cell development
Nkx2.2 is required for the primary induction of most endo-
crine cell lineages; inNkx2.2!/! embryos, ghrelin-expressing
Papizan et al.
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cells form at the expense of all b cells and the majority of
a and PP cells (Sussel et al. 1998). To determine whether
the disrupted islet structure and abnormal islet cell ratios
observed in the Nkx2.2TNmut/TNmut adult mice are caused
by pancreatic defects manifested during embryonic de-
velopment, we assessed endocrine cell formation in
Nkx2.2TNmut/TNmut embryos. Unlike the Nkx2.2!/! em-
bryos, which already display endocrine cell differentiation
phenotypes by E9.5, the Nkx2.2TNmut/TNmut embryos
display no apparent defects in a- and b-cell numbers at
E12.5 (Fig. 3A–C). In agreement with the cell quantifica-
tion, there are no detectable differences in glucagon or
insulin gene expression between the Nkx2.2TNmut/TNmut
embryos and their wild-type littermates (Fig. 3L). By E13.5,
however, at the onset of the secondary transition, there is
a reduction in b-cell numbers and insulin expression, with
a corresponding increase in e-cell numbers and ghrelin
expression (Fig. 3L; Supplemental Fig. 1D–F,I,J). At E15.5,
during the peak of endocrine cell differentiation, insulin-
producing b-cell numbers remain significantly decreased,
with a corresponding reduction in insulin (ins1 and ins2)
gene expression (Fig. 3D,E,H,L; data not shown). The
reduction in b-cell numbers does not appear to be due
to apoptosis, as indicated by the absence of caspase3
expression in the insulin-producing cell populations or
elsewhere in the pancreas (Supplemental Fig. 2A–D).
Furthermore, e-cell numbers and ghrelin gene expression
are increased concomitantly with the loss of b cells,
suggesting that, similar to the Nkx2.2!/! allele, e cells
are forming at the expense of the b-cell population (Fig. 3F–
H,L). These phenotypes persist through the end of gesta-
tion (Fig. 3I–L).
Surprisingly, in contrast to the Nkx2.2!/! phenotype,
there is a significant increase in both a-cell numbers and
glucagon gene expression in the Nkx2.2TNmut/TNmut
pancreata by E18.5 (Fig. 3I–L). The increase in a cells
does not appear to be caused by excessive replication,
since we do not detect proliferating glucagon-positive
cells before or during expansion of the a-cell population
(Supplemental Fig. 2E–H). Although there is an increase
in the numbers of a and e single-hormone-positive cells,
this is not associated with an increase in the glucagon+
ghrelin+ coexpressing population (data not shown). In
contrast, we do observe an increase in the number of
cells that coexpress insulin and glucagon, despite the
total reduction in b-cell numbers (Fig. 3E,J, insets).
Throughout gestation, PP and somatostatin levels remain
unaffected in Nkx2.2TNmut/TNmut pancreata, and there
are no obvious changes in exocrine tissue morphology,
acinar cell numbers, or exocrine enzyme gene expression
(Fig. 3L; data not shown).
Islet cell-specific transcription factor expression
is disrupted in Nkx2.2TNmut/TNmut pancreas
Interestingly, the Nkx2.2TNmut/TNmut phenotype differs
substantially from that observed in the Nkx2.2!/! em-
bryos. While the less severe b-cell and e-cell phenotypes
could be attributed to mutations in the TN domain,
having a more moderate reduction in Nkx2.2 function
than the null allele, the resulting increase in a-cell
numbers is more difficult to interpret. To begin to
characterize the underlying molecular changes that may
be contributing to the Nkx2.2TNmut/TNmut endocrine cell
Figure 1. The Nkx2.2 TN domain mutation
disrupts the Nkx2.2–Grg3 interaction. (A)
Recombinase-mediated cassette exchange
(RMCE) was used to knock-in amino acid
substitutions into the Nkx2.2 TN domain.
The mutations are shown in red. (B) Allele-
specific primers were used to distinguish be-
tween wild-type and mutant alleles when
genotyping. (C) At birth, Nkx2.2TNmut/TNmut
pancreata exhibit normal size and morphology
compared with wild-type mice (n = 3). (D)
H&E-stained section of wild-type and mutant
pancreas showing normal endocrine and aci-
nar morphology (n = 3). (E) Quantitative PCR
demonstrates that Nkx2.2 transcript levels
from whole embryonic pancreas (E18.5) are
unchanged in the mutant (n = 5). (F) Protein
levels of Nkx2.2 are unchanged in P0 pups.
Lamin B1 was used as a loading control (n =
5). (G) Coimmunoprecipitation of Grg3 and
Nkx2.2 from whole pancreas at birth demon-
strates a loss of interaction between the
two proteins in the Nkx2.2TNmut/TNmut mice
(n = 3).
Nkx2.2 maintains islet b-cell identity
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phenotype, we assessed the expression of several pancre-
atic developmental markers at E14.5, when alterations in
insulin and ghrelin cell populations are evident. Similar
to Nkx2.2!/! mice, expression of Pdx1 is unchanged at
E14.5 and we see a reduction in Ngn3 expression,
although there is no apparent reduction in the endocrine
progenitor population (Fig. 4A; Anderson et al. 2009; data
not shown). In contrast to the Nkx2.2!/! mice, Nkx6.1
expression is not significantly down-regulated at E14.5
(Fig. 4A).
By E18.5, altered expression of the islet lineage-specific
factors corresponded well with the observed changes in
islet cell ratios caused by the TN domain mutation.
Consistent with the reduction in b-cell numbers, Pdx1,
NeuroD, and MafA are significantly decreased by E18.5
(Fig. 4B). Alternatively, the a-cell markers Arx and Irx2
are significantly elevated by E18.5, with increases in Arx
expression being close to 70-fold over wild-type levels
(Fig. 4B). MafB expression does not appear changed; how-
ever, this may be attributed to the fact that MafB is
expressed in both a- and b-cell populations during embryo-
genesis; the loss of MafB-expressing b cells would be
compensated by the increase in MafB-expressing a cells.
By 4wk of age,MafB is expressed in the a cells in bothwild-
type and Nkx2.2TNmut/TNmut mice (Supplemental Fig. 3).
Interestingly, although the general changes in expres-
sion levels of the a- and b-cell-specific genes corre-
sponded well with the observed alterations in the
a- and b-cell numbers in the Nkx2.2TNmut/TNmut em-
bryos, we could detect a threefold to fourfold increase
in the expression of the a-cell transcription factor Arx
at E15.5, prior to a significant increase in the number
of glucagon+ cells (Fig. 4C). To identify the cellular
source of increased Arx expression, we performed
immunofluorescence analysis to correlate Arx expres-
sion with the different pancreatic populations. At
E15.5, we observe a large increase in the number of
Arx-expressing cells that do not coexpress glucagon
in the Nkx2.2TNmut/TNmut (Fig. 4D,E). Surprisingly, at
the same stage of development, we begin to observe
a number of insulin-producing cells that ectopically
express Arx (Fig. 4F,G). By the end of gestation, the
Nkx2.2TNmut/TNmut pancreas contains Arx+, insulin+ b
cells and Arx+, glucagon+ a cells, whereas pancreata
from wild-type littermates show mutually exclusive
expression of Arx and insulin. (Fig. 4H,I,L).
Mutation of the Nkx2.2 TN domain results
in a b-to-a-cell conversion due to the ectopic
expression of Arx in b cells
Previous studies have demonstrated that misexpression
of Arx in embryonic b cells is sufficient to convert b cells
into a cells (Collombat et al. 2007). Since we observe
elevated Arx expression and Arx+ insulin-producing cells
at E15.5, prior to a significant increase in a-cell numbers,
we postulated that mutation of the Nkx2.2 TN domain
may cause aberrant derepression of theArx gene in b cells
to trigger their transdifferentiation into a cells. To test
this hypothesis, we generated Nkx2.2TNmut/TNmut mice
carrying the Ins:Cre transgene (Herrera 2000) and ei-
ther the Rosa26:tomato or Rosa26:LacZ reporter alleles
(Soriano 1999; Madisen et al. 2010) to allow us to lineage
trace the mutant b cells. While Rosa26 reporter expres-
sion is restricted to the insulin-expressing population in
control Nkx2.2+/+;Ins:Cre;Rosa26:LacZ/tomato islets (Fig.
4J; Supplemental Fig. 4A,B), we detect Rosa26:tomato
reporter expression in >2% of the glucagon-expressing cells
of the Nkx2.2TNmut/TNmut ;Ins:Cre; Rosa26:LacZ/tomato
islets at postnatal day 0 (P0) (Fig. 4K,L; Supplemental Fig.
4C,J). Many of the glucagon and tomato double-positive
cells coexpress Arx, supporting the idea that Arx is up-
regulated in the b-cell-derived glucagon-expressing pop-
ulation that appears in the absence of functional Nkx2.2
(Fig. 4L). Consistent with the discovery that b cells are
reprogrammed to an a-cell fate in the Nkx2.2TNmut/TNmut
mice, expression of a number of b-cell transcription
factors—including Pdx1, MafA, and Nkx6.1—can be de-
tected in a small population of cells that are in the process
of converting to glucagon-expressing a cells (Supplemen-
tal Fig. 4D–I). The insulin- and glucagon-coexpressing
population present in the Nkx2.2TNmut/TNmut pan-
creas may also represent this transitioning population
(Fig. 3E,J). It should be noted that costaining of to-
mato with ghrelin cannot be detected, indicating, in
Figure 2. Nkx2.2TNmut/TNmut mice develop diabetes. (A)
Nkx2.2TNmut/TNmut mice exhibit hyperglycemia during fed and
fasted states (n = 5). (B,C) Wild-type and mutant islet at 6 wk
old immunostained for insulin and glucagon. By 6 wk of age,
the Nkx2.2TNmut/TNmut mice contain smaller islets with fewer
b cells and more a cells (n = 3). (D–F) Quantification of b cells
and a cells at 4 wk of age demonstrates a significant loss of
b cells and a significant increase in a cells, while no change in
total islet number was observed (n = 3). (*) P < 0.05; (***) P < 0.001.
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contrast to the a-cell lineage, the observed increase in e
cells is not due to b-cell reprogramming (Supplemental
Fig. 4K,L).
Since the Nkx2.2TNmut/TNmut pups are not born with
a metabolic phenotype but continue to lose b cells and
become increasingly hyperglycemic with age, we wished
to determine whether the b-to-a-cell conversion con-
tinues to occur in postnatal animals. For this analysis,
we generated Nkx2.2TNmut/TNmut mice carrying the
Pdx1:CreER transgene (Gu et al. 2002) and the Rosa26:
tomato reporter allele. To avoid outcomes that could
be associated with a hyperglycemic environment, we
induced 3-wk-old mice with tamoxifen prior to the onset
of overt hyperglycemia (Supplemental Fig. 1). Five days
following tamoxifen induction, we can detect tomato
reporter expression in glucagon-producing a cells in the
Nkx2.2TNmut/TNmut; Pdx1:CreER; Rosa26:tomato islets
(n = 3), indicating that b-to-a-cell reprogramming con-
tinues to occur postnatally (Supplemental Fig. 5A–D).
Glucagon expression and tomato reporter expression
were mutually exclusive in control Nkx2.2TNmut/+;
Pdx1:CreER; Rosa26:tomato littermates receiving tamox-
ifen. Nkx2.2TNmut/TNmut; Pdx1:CreER; Rosa26:tomato
islets that did not receive tamoxifen were devoid of
Figure 3. Nkx2.2TNmut/TNmut mice display de-
creased insulin expression and increased glucagon
and ghrelin expression. (A–L) Characterization of
insulin-, glucagon-, and ghrelin-expressing cells
in Nkx2.2TNmut/TNmut mice (n = 3–5). (A–C,L)
Hormone-positive cell numbers and expression
were unaltered at E12.5. (D–H,L) By E15.5,
Nkx2.2TNmut/TNmut mice display increased e-cell
numbers, slightly elevated a-cell numbers, and
decreased numbers of b cells. (I–L) By E18.5, the
glucagon population is significantly increased,
while the insulin and ghrelin populations remain
decreased and increased, respectively. (*) P <
0.05. Arrowheads indicate glucagon/insulin cos-
taining in E and J.
Nkx2.2 maintains islet b-cell identity
GENES & DEVELOPMENT 2295
 Cold Spring Harbor Laboratory Press on August 13, 2012 - Published by genesdev.cshlp.orgDownloaded from 




tomato reporter expression, as expected (Supplemental
Fig. 5E,F).
Nkx2.2 directly binds and represses the methylated
Arx promoter in b cells
Given the dramatic increase in Arx expression in the
Nkx2.2TNmut/TNmut b cells, it is possible that disruption
of the interaction between Nkx2.2 and Grg3 interferes
with repression of the Arx promoter in b cells. To
determine whether Arx is a direct target of Nkx2.2, we
performed in silico analysis of the Arx promoter to
identify a highly conserved Nkx2.2-binding site located
;1.4 kb upstream of the transcriptional start site (Sup-
plemental Fig. 6A; Hill et al. 2011). Chromatin immuno-
precipitation (ChIP) of this region with Nkx2.2 antibody
in islet cell lines demonstrated that endogenous Nkx2.2
normally occupies this region of theArx promoter in both
a and b cells, although binding is significantly enriched in
bTC6 cells (Fig. 5A). Furthermore, Grg3 and HDAC1 are
preferentially recruited to the Arx promoter in b cells,
supporting the idea that Nkx2.2 may function to recruit
Grg3 to repress Arx expression in the b-cell population.
Further analysis of theArx promoter revealed the presence
Figure 4. Mutations in the Nkx2.2 TN domain cause Arxmisexpression in b cells and b-to-a-cell reprogramming. (A) Islet cell-specific
transcription factor expression at E14.5 (n = 5). (B) By E18.5, b-cell factors are reduced, while a-cell factors are increased, reflecting the
changes associated with these cell types (n = 5). (C) Nkx2.2TNmut/TNmut mice exhibit a threefold to fourfold increase in Arx expression
at E15.5, prior to the changes in glucagon expression and a-cell number (n = 5). (D,E) There are increased numbers of Arx+ cells and
more Arx+/glucagon! cells in Nkx2.2TNmut/TNmut mice at E15.5, when the increase in Arx expression is first observed. (F–I) Between
E15.5 and continuing through gestation, Arx is misexpressed in the b-cell population of Nkx2.2TNmut/TNmut mice. (J,K) Using the b-cell-
specific Ins:Cre and the Rosa26:tomato reporter, b-cell-derived glucagon-positive cells are frequently detected in Nkx2.2TNmut/TNmut
mice. (L) b-Cell-derived a cells express Arx (n = 3). (*) P < 0.05; (**) P < 0.01. Arrowheads in E indicate Arx+/glucagon! cells. Arrowheads
in G, I, and K indicate copositive cells. Arrowheads in L indicate triple-positive cells.
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of CpG islands surrounding the conserved Nkx2.2-binding
site, which, if methylated, could also contribute to the
mechanism of Arx repression in b cells. Accordingly,
bisulfite analysis for the Nkx2.2-binding region of the
Arx promoter identified differential methylation patterns
in b versus a cells; theArx promoter is hypermethylated in
b cells (Fig. 5B). Since the de novo DNAmethyltransferase
Dnmt3a has been shown to be important for establishing
methylation patterns during development and promotes
site-specific methylation through its interaction with tran-
scription factors (Hervouet et al. 2009), we investigated
whether Dnmt3a was also differentially present on the
Figure 5. Nkx2.2 directly represses Arx in bTC6 cells but not aTC1 cells. (A) Nkx2.2, Grg3, HDAC1, and Dnmt3a are highly enriched
on the Arx promoter in bTC6 cells (n = 3). (B) Bisulfite sequencing analysis and quantification for the Nkx2.2-binding region of Arx
locus (!1660 to !1463 base pairs [bp] and !1374 to !1162) in isolated b and a cells. (C) Coimmunoprecipitation analysis for the
interaction of Dnmt3a with Nkx2.2, Grg3, HDAC1, Pax4, and Isl1 using immunoprecipitation with Flag tag antibody on Min6 cells
transfected with Flag-Dnmt3a construct, and Western blotting with Flag tag, Nkx2.2, Grg3, HDAC1, Pax4, and Isl1 antibodies. (D)
Nkx2.2 induces the expression of a 2.5-kb region of the Arx promoter fused to luciferase in aTC1 cells. Nkx2.2 represses the Arx
promoter activity 3.5-fold in bTC6 cells (n = 4). (E) Immunostaining of representative pancreatic sections from 3-mo-old Dnmt3afl/fl
(control) and Ins:Cre:Dnmt3afl/fl littermates for insulin and glucagon. (F) Representative pancreatic section from a 3-mo-old
Ins:Cre:Dnmt3afl/fl:Rosa26:LacZ animal showing immunostaining for glucagon in the left panel and an overlay of glucagon with
b-galactosidase activity (LacZ), in the right panel. The inset marks a magnified representative area, showing a number of LacZ and
glucagon double-labeled cells (white arrows). (***) P < 0.001 versus a TC; (#) P < 0.05; (###) P < 0.001 versus IgG in A. (**) P < 0.01
versus b cells in B. (***) P < 0.001 versus Arx promoter in D.
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Arx promoter. Consistent with a role for Dnmt3a in the
cell-specific regulation of Arx promoter methylation,
Dnmt3a occupies the Arx promoter specifically in b cells
(Fig. 5A). Furthermore, coimmunoprecipitation analysis
demonstrates that Flag-tagged Dnmt3a can form a protein
complex with Nkx2.2, but not other b-cell factors such as
Pax4 and Isl1 (Fig. 5C). Grg3 and HDAC1 are also part of
this complex, suggesting that Dnmt3a and Nkx2.2 co-
operate to facilitate recruitment of a repressor complex to
theArx promoter in b cells. Interestingly, the Nkx2.2 TN
domain appears to be dispensable for a direct interaction
between Nkx2.2 and Dnmt3a (Supplemental Fig. 6B),
suggesting that the two factors interact through another
Nkx2.2 domain and/or through other proteins within the
complex.
To investigate whether Nkx2.2 specifically represses
the Arx promoter in b cells, we subcloned a 2.5-kb region
of the Arx promoter located upstream of the transcrip-
tional start site into the pGL3 basic promoter-less lucif-
erase reporter vector. Cotransfection of pGL3-Arx and
Nkx2.2 into aTC1 cell lines resulted in a significant
induction of Arx transcriptional activity, whereas
cotransfection of pGL3-Arx and Nkx2.2 into bTC6 cell
lines elicited a 65% repression of transcription (Fig. 5D).
These data suggest that Nkx2.2 represses Arx activity in
b cells through its interaction with Dnmt3a and Grg3 and
preferential recruitment of HDAC1 to the Arx promoter
in b cells. These findings are consistent with the in vivo
results, suggesting that the Nkx2.2 TN domain is essen-
tial for the recruitment of Grg3 and maintaining repres-
sion of Arx in the b-cell population.
b-Cell-specific deletion of Dnmt3a also results
in a b-to-a-cell conversion
Given the enrichment of Dnmt3a on the Arx promoter in
b cells and its presence in the Nkx2.2, Grg3, and HDAC1
repressor complex, we wished to determine whether
Dnmt3a is critical for proper islet cell type maintenance,
similar to Nkx2.2. Interestingly, mice with a b-cell-
specific deletion of Dnmt3a (Ins:Cre; Dnmt3afl/fl) pheno-
copy the Nkx2.2TNmut/TNmut mice; a cells are increased
with a corresponding loss of b cells (Fig. 5E). Furthermore,
genetic lineage tracing in Ins:Cre;Dnmt3afl/fl;Rosa26:LacZ
mice demonstrates that the b-cell loss associated with
deletion of Dnmt3a results in b-to-a-cell transdifferentia-
tion, similar to the Nkx2.2TNmut/TNmut mice (Fig. 5F).
Removal of Arx from Nkx2.2TNmut/TNmut b cells
is sufficient to prevent b-cell reprogramming,
but fails to restore b-cell maturation and function
To determine whether inhibiting the ectopic expression of
Arx inb cells is sufficient to prevent theNkx2.2TNmut/TNmut
b-to-a-cell reprogramming phenotype, we crossed Ins:Cre;
Arxfl/fl mice (Herrera 2000; Marsh et al. 2009) into the
Nkx2.2TNmut/TNmut background to generate mice that
would remove the ectopically expressed Arx specifically
from the Nkx2.2TNmut/TNmut b cells. Wild-type mice do
not normally express Arx in b cells, and, accordingly,
Ins:Cre; Arxfl/fl mice develop normal islets and are in-
distinguishable from wild-type mice (Supplemental
Fig. 7A). Alternatively, deletion of Arx from the b cells
of Nkx2.2TNmut/TNmut mice returned Arx to wild-type
expression levels, confirming that the elevated Arx
expression was due primarily to its ectopic expression
in b cells (Fig. 6G). Furthermore, removal of Arx from
Nkx2.2TNmut/TNmut b cells normalized both glucagon
mRNA levels and a-cell numbers (Fig. 6B,D,F,G). Lineage
tracing of the b cells in the Nkx2.2TNmut/TNmut;Ins:Cre;
Arxfl/fl mice did not identify any b-cell-derived glucagon-
expressing cells (Fig. 6J,K), suggesting that the deletion of
Arx is sufficient to prevent the b-to-a-cell transdifferen-
tiation. On the other hand, the b-cell deletion ofArx is not
sufficient to restore b-cell numbers or insulin expression
at E18.5, and adult Nkx2.2TNmut/TNmut; Ins:Cre;Arxfl/fl
mice remained hyperglycemic (Fig. 6A,C,E,G–I). This
suggests that the TN domain regulates additional
Nkx2.2 targets, which are responsible for b-cell forma-
tion, maintenance, and function. Similarly, elevated
ghrelin levels are unaffected by the removal of Arx from
the Nkx2.2TNmut/TNmut mutant b cells, demonstrating
that Arx-independent Nkx2.2 TN domain functions are
also required for the e- versus b-cell fate choice during
embryogenesis (Fig. 6G).
To investigate whether the Ins:Cre; Dnmt3afl/fl pheno-
type is also dependent on Arx, we tested whether simul-
taneous depletion of Dnmt3a and Arx could rescue the
b-to-a-cell transdifferentiation process. siRNAs targeting
Dnmt3a, Arx, or a combination of the two genes were
transfected into Min6 cells. Similar to the Ins:Cre;
Dnmt3afl/fl mice, knockdown of Dnmt3a in Min6 cells
resulted in b-to-a-cell reprogramming: Expression of in-
sulin, Pdx1, and Pax4 was reduced, with a concomitant
up-regulation of glucagon, Arx, and MafB. Combined
siRNA knockdown of Arx with Dnmt3a was able to
prevent the corresponding alterations in a- and b-cell
marker expression, indicating that, similar to Nkx2.2,
Dnmt3a-mediated reprogramming is dependent on Arx
misexpression (Supplemental Fig. 7B).
Discussion
Transcriptional repression is widely appreciated for its
role in determining lineage and cell specification, as
repressive mechanisms are known to be key regulators
of cellular commitment in many tissues and organisms
(Gray et al. 1995; Gray and Levine 1996; Laslo et al. 2006;
Jepsen et al. 2007; Rajasekhar and Begemann 2007; Li and
Davidson 2009; Nishi et al. 2009). Nkx2.2 has been
shown to act as a transcriptional repressor to regulate
ventral neural patterning through its interaction with the
corepressor Grg4 (Muhr et al. 2001). The ability of Nkx2.2
to act as a transcriptional repressor in the developing
pancreas has also been shown (Doyle et al. 2007). Grg2
and Grg3, rather than Grg4, are coexpressed with Nkx2.2
in the pancreas and can also interact with Nkx2.2
through the groucho interaction TN domain (Doyle
et al. 2007; Hoffman et al. 2008). In this study, we
mutated the Nkx2.2 TN domain to determine the role
Papizan et al.
2298 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on August 13, 2012 - Published by genesdev.cshlp.orgDownloaded from 




of Grg-mediated Nkx2.2 repressor activity in the devel-
oping pancreas. We demonstrate that mutation of the
Nkx2.2 TN domain abolishes the interaction between
Nkx2.2 and Grg3 protein in vivo, and this is sufficient
to cause a shift from the b-cell to the e-cell lineage.
Furthermore, many of the remaining b cells are repro-
grammed into a cells due to the b-cell-specific derepres-
sion of the a-cell regulator Arx. Remarkably, it appears
that Arx is the primary downstream target of Nkx2.2 in
the maintenance of b-cell fate; removal of Arx from the
Nkx2.2TNmut/TNmut b cells appears to completely inhibit
the b-to-a-cell conversion.
The phenotypes associated with Nkx2.2TNmut/TNmut
suggest that TN domain-mediated functions are required
in two distinct processes within the pancreas: primary
islet cell fate decisions and maintenance of b-cell iden-
tity. Initially, the TN domain appears to influence the
competency of the Ngn3+ endocrine progenitor to differ-
entiate into e cells versus b cells, similar to what we
observed in the Nkx2.2!/!-null mice. A proposed defect
in cell fate choice regulation is supported by the obser-
vation that the corresponding alterations of b-cell and
e-cell ratios occurs at the onset of the secondary transi-
tion, which marks the first major wave of b-cell differen-
tiation. Furthermore, we demonstrated that the increase
in ghrelin-producing cells is not due to reprogramming of
the b-cell population, since we did not observe ghrelin
cells that were derived from the lineage-labeled b-cell
population (Supplemental Fig. 4L). Although the
Nkx2.2TNmut/TNmut and Nkx2.2!/! mice both display
an increase in e-cell numbers, coupled with a correspond-
ing decrease in b cells, the phenotype is much more
dramatic in the Nkx2.2!/! mice, which have a complete
absence of b cells at all developmental stages. The less
severe phenotype associated with theNkx2.2TNmut/TNmut
mice could indicate that the interaction between Nkx2.2
and Grgs is not completely disrupted, and residual
activity is sufficient to allow for the formation of a small
number of b cells. Alternatively, it is possible that other
domains of the Nkx2.2 protein are responsible for b-cell
formation during the primary transition stage of pancreas
development, which would be consistent with the absence
Figure 6. b-cell-specific loss of Arx in the
Nkx2.2TNmut/TNmut mice rescues glucagon
and Arx expression. (A–F) Characterization
of insulin- and glucagon hormone-positive
cells (n = 3). (G) Transcript levels of hor-
mones in wild-type, Nkx2.2TNmut/TNmut,
and Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice
(n = 5). (H) Fed blood glucose levels in
7-wk-old male and female mice (n = 5).
(I) Quantification of b cells as a percentage
of total pancreas area in wild-type,
Nkx2.2TNmut/TNmut, andNkx2.2TNmut/TNmut;
Ins:Cre;Arxfl/fl mice. (J,K) Using the b-cell-
specific Ins:Cre and the Rosa26:tomato
reporter, b-cell-derived ghrelin-positive
cells are not detected in Nkx2.2TNmut/TNmut
mutant mice (n = 3). (*) P < 0.05; (**) P <
0.01; (***)P < 0.001 versus wild type. (#) P <
0.05 versus Nkx2.2TNmut/TNmut.
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of a b-cell phenotype in the Nkx2.2TNmut/TNmut mice prior
to E12.5 (Fig. 3A–C). A third possibility is that additional
Nkx2.2 protein domains can compensate for the loss of
TN domain activity to allow the formation of a small
number of b cells throughout development. These possi-
bilities are not mutually exclusive and will be explored in
future studies to gain a more complete understanding of
the role of Grg-mediated regulation of Nkx2.2 function in
b-cell lineage decisions.
The Nkx2.2 TN domain also appears to play a distinct
role in maintaining the b cells that are able to form in the
Nkx2.2TNmut/TNmut mice. We show that by E18.5, there is
an additional reduction in b cells that corresponds to an
unexpected increase in a-cell numbers. Unlike the early
changes we observed in b-cell versus e-cell ratios, we do
not observe a significant increase in a-cell numbers until
the end of gestation. The observation that a-cell genes are
becoming ectopically expressed in insulin-producing pop-
ulations, combined with the b-cell lineage-tracing analy-
sis, indicates that many of the a cells are derived from
insulin-producing cells. This implies that Nkx2.2 is
functioning within the b cell to maintain its cellular
identity and prevent transdifferentiation into the a-cell
fate. Interestingly, in the Nkx2.2TNmut/TNmut mice, we do
not observe immediate and simultaneous reprogramming
of all b cells in response to dysregulation of Arx. Instead,
the transdifferentiation event occurs gradually over time
and continues in the postnatal animal. This would
suggest that, in addition to the activation of a-cell lineage
inducers, such as Arx, a number of additional (perhaps
more resistant) cellular events, such as global chromatin
remodeling, must occur to allow reprogramming to be
initiated. Further epigenetic analyses and gene expression
profiling of FACs-purified b-cell populations derived from
the Nkx2.2TNmut/TNmut mice during intermediate stages
of transdifferentiation may elucidate the b-cell-determin-
ing features that must be overcome to allow b-to-a-cell
reprogramming.
Interestingly, the Nkx2.2TNmut/TNmut mice also differ
quite significantly from the Nkx2.2!/! phenotype with
regards to PP- and a-cell formation. Unlike theNkx2.2!/!
mice, which display an;50% reduction in PP cells, there
is no apparent change in PP-cell numbers or PPY expres-
sion in the Nkx2.2TNmut/TNmut mice, suggesting that
PP-cell formation is not regulated by TN domain func-
tions. Even more puzzling was the unexpected a-cell
phenotype associated with the Nkx2.2TNmut/TNmut mice.
We previously demonstrated that the Pdx1:Nkx2.2hdEnR
repressor derivative was sufficient to fully rescue a-cell
numbers in the Nkx2.2!/! mice (Doyle et al. 2007),
suggesting that Nkx2.2 repressor function is sufficient
for a-cell formation. However, removal of the Nkx2.2
TN repressor domain does not appear to negatively affect
the a-cell population at any stage of development, and
instead we observe an increase in a-cell numbers. This
may indicate that Grg-dependent repression is dispens-
able for the a-cell lineage specification or perhaps that
other regions of the Nkx2.2 protein can compensate
for the loss of this interaction and/or provide an alterna-
tive mechanism of repressive activity. We are currently
exploring the possibility that the conserved NK2-SD
domain, the defining domain of the Nkx2 family, can
contribute to Nkx2.2 repressor activity in vivo, as has
been suggested previously (Watada et al. 2000). The
data presented here now give us a greater understanding
of a previously unanticipated role for the Nkx2.2 TN
domain in maintaining b-cell identity through its re-
pression of the Arx promoter in b cells. This function
would not be revealed in Nkx2.2!/! mice, since there
are no b cells available to reprogram. This unexpected
result not only begins to elucidate the distinct functions
of Nkx2.2 in different islet cell types and at different
stages of development, but also emphasizes the useful-
ness of generating hypomorphic and/or domain-specific
alleles to understand the nuances of a protein’s function
in vivo.
Our study also re-emphasizes the importance of main-
taining the appropriate regulation of Arx expression in
the different islet cell types. Previous studies have dem-
onstrated that Arx is essential for specifying the a- and
PP-cell lineages (Collombat et al. 2003, 2005, 2007).
Disruption of Arx leads to reduced numbers of a cells
coupled with a corresponding increase in b and d cells
(Collombat et al. 2003). Alternatively, misexpression of
Arx in b cells is sufficient to convert b cells to a or PP
cells (Collombat et al. 2007). Interestingly, although we
recapitulate the b-to-a-cell reprogramming phenomenon
with the derepression of Arx in b cells, we are unable to
detect significant changes in PP expression. It is possible
that the increased levels of Arx caused by the Nkx2.2 TN
mutation are sufficient for the a-cell fate but are not
sufficient for conversion to a PP-cell fate. This is consis-
tent with studies showing that protein expression levels
and dosing requirements of transcription factors are
important for controlling islet cell development and islet
cell fate choices (Fujitani et al. 2006; Wang et al. 2009).
Alternatively, removal of the Nkx2.2 TN domain likely
affects additional downstream effectors that may func-
tion to counter the Arx regulation of the PP fate.
Differential expression of transcription factors can
allow for tissue- and cell-specific gene regulation; how-
ever, when a factor is expressed in more than one cell
type, higher-order regulation will be required to control
cell- and/or promoter-specific regulation. Differential
promoter regulation can be achieved by cell-specific
cofactor interactions or at the level of DNA accessibility
or both. In the case of Nkx2.2, we demonstrated that
it preferentially binds the Arx promoter in b cells,
although Nkx2.2 is expressed and functions in both a
and b cells. The differential binding ability of Nkx2.2
may be influenced by the methylation state of the Arx
promoter that surrounds the Nkx2.2 consensus binding
site and is possibly facilitated by the DNAmodifications
induced by Dnmt3a. A cooperative role between these
factors for maintaining b-cell-specific Arx repression
and b-cell identity is supported by the similar repro-
gramming phenotypes displayed by the b-cell-specific
deletion of Dnmt3a and the Nkx2.2 TN mutant mice.
Therefore, it is possible that differential DNA methyla-
tion and the presence of Dnmt3a on the Arx promoter
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provide a cell-specific platform for Nkx2.2 binding on
the Arx promoter in b cells. However, Dnmt3a is also
expressed in both a and b cells, suggesting that its
preferential recruitment to the Arx promoter in b cells
must also rely on a b-cell-specific factor. Nkx6.1 is
a possible candidate for mediating b-cell-specific re-
cruitment of Dnmt3a to the Arx promoter, and we are
able to demonstrate that Nkx6.1 is also present on the
Arx promoter in b cells (Supplemental Fig. 6). Further
studies will be necessary to determine the sequence of
events that occur on the Arx promoter with regards to
protein recruitment and DNA methylation to initiate
and maintain transcriptional repression ofArx in b cells.
Since we can also detect Nkx2.2 bound to the Arx
promoter in a cells, albeit at lower levels, it remains
possible that Nkx2.2-mediated repression of Arx in b
cells also depends on a combinatorial effect between
methyl-binding proteins and Nkx2.2. Dhawan et al.
(2011) demonstrated that the methyl-binding protein
MeCP2 is also bound to the methylated Arx promoter
in b cells. Methyl-binding proteins have been shown to
tether histone deacetylase complexes, such as NuRD, to
methylated DNA (Zhang et al. 1999). Furthermore, re-
cruitment of these repressor complexes can be facilitated
by sequence-specific transcription factors (Kehle et al.
1998; Liang et al. 2008; Fu et al. 2011). Since Nkx2.2
preferentially recruits Grg3 and HDAC1 to the Arx pro-
moter in b cells, it is possible that Nkx2.2 cooperates
with methyl-binding proteins to recruit histone deacety-
lases and achieve repression of Arx. Since it appears that
the initiation and maintenance of Arx expression in b
cells is crucial for maintaining b-cell identity, it is likely
that a combination of these mechanisms is necessary to
cooperatively repress Arx and retain b-cell integrity
(schematized in Fig. 7A). Additionally, given the small
but significant recruitment of Nkx2.2 and Grg3 to the
Arx promoter in a cells (Fig. 5A) and the Nkx2.2-medi-
ated induction of Arx in a cells (Fig. 5D), we cannot rule
out the possibility that Nkx2.2 and Grg3 may be facili-
tating the activation of Arx in a cells. While Grgs are
generally described as corepressors, a recent study dem-
onstrated that Grg3 is able to function as both an
activator and a repressor during adipogenesis (Villanueva
et al. 2011).
Lineage-specific gene expression patterns rely on a com-
plex interplay between transcription factors, cofactors,
and DNA accessibility. This process becomes muchmore
complicated when a single factor has differential func-
tions across development and within unique cell types.
Our analysis highlights the complex regulation of lineage
Figure 7. Model of Nkx2.2 regulation of the Arx
promoter in b cells. (A) Our data, in combination
with the study by Dhawan et al. (2011), support
a model whereby a repressor complex comprised of
Nkx2.2, Grg3, and Dnmt3a preferentially recruits
HDAC1 to the Arx promoter to silence Arx expres-
sion specifically in the pancreatic b cells to prevent
b-to-a-cell conversion. We can also detect the pres-
ence of Nkx6.1 bound to this promoter region,
which possibly confers cell-specific recruitment of
the Nkx2.2/Dnmt3a complex to the Arx promoter.
Since Nkx2.2TNmut/TNmut mice no longer retain
a Nkx2.2/Grg3 interaction, Grg3 and HDAC1 are
no longer recruited to the Arx promoter, allowing
ectopic expression of Arx in b cells. It is not yet
known whether Nkx2.2TNmut/TNmut mice affect
Dnmt3a recruitment and subsequent methylation
of the Arx promoter. (B) Grg3-mediated Nkx2.2
repression controls two developmental stages of
pancreas development. We first observe aberrations
in the proper specification of b and e cells at E13.5 in
the Nkx2.2TNmut/TNmut mice, when an increased
number of e cells are forming at the expense of b
cells. The remaining b cells then go on to trans-
differentiate to a cells. This transdifferentiation is
evident by E18.5 and continues to occur postnatally.
Nkx2.2 maintains islet b-cell identity
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commitment within the endocrine pancreas and draws
attention to the need to dissect out the cell-specific
functions of each regulatory factor to fully understand
lineage specification and maintenance. The phenotype of
mice carrying a disruption of the Nkx2.2 TN domain has
revealed that the Grg-mediated repressor activity of
Nkx2.2 controls two stages of development (schematized
in Fig. 7B): (1) Grg-mediated Nkx2.2 repression is not
required for the early commitment of b versus a cells, but
is required for the correct balance of b and e cells that
form at the beginning of the secondary transition. (2) The
functions mediated by this interaction are also critical for
the maintenance of b-cell identity by preventing ectopic
expression of Arx in b cells. This emphasizes the impor-
tance of understanding the spatial and temporal regula-
tion of cofactors in lineage commitment decisions and
underscores the potential importance of epigenetic and
transcription factor interactions to further regulate pro-
moter occupancy. Our studies, coupled with those of
Dhawan et al. (2011), suggest that Nkx6.1, Nkx2.2,
Dnmt3a, and MeCP2 converge on methylated DNA of
the Arx promoter specifically in b cells to recruit histone
modifiers (HDAC1 and PRMT6, respectively), in order to
silence Arx expression (schematized in Fig. 7). Further
understanding of the precise molecular events of islet
cell-specific transcriptional networks on individual pro-
moters will aid in formulating effective protocols to
induce and maintain appropriate endocrine lineage com-
mitment from alternative cell sources, such as embryonic
stem cells or induced pluripotent cells, for the treatment
of diabetes.
Materials and methods
Generation of Nkx2.2TNmut mice
The Nkx2.2 TN domain mutant (Nkx2.2TNmut) mice were
generated using the two-step recombination-mediated cassette
exchange (RMCE) technology (Chen et al. 2011) to insert amino
acid substitutions in the endogenous Nkx2.2 locus. To do so, we
first engineered an Nkx2.2 loxed cassette acceptor (Nkx2.2LCA)
allele using the strategy and plasmids described in Chen
et al. (2011) (L Arnes, K Leclerc, JM Friel, SB Hipkens, MA
Magnuson, and L Sussel, in prep.). Second, to generate the
Nkx2.2TNmut allele, we then made a basal exchange Nkx2.2
targeting vector containing a 5.1-kb genomic (129-S6) DNA
fragment encompassing the two Nkx2.2 coding exons. PCR-
mediated site-directed mutation of the TN domain was per-
formed using the QuikChange Site-Directed Mutagenesis kit
(Stratagene) to replace the conserved TN domain core SVKD12–15
amino acids with four alanine residues and the invariant leucine
(L17) with valine, an equally hydrophobic amino acid. We also
introduced a SalI restriction site for genotyping purposes. All
mutations were verified by DNA sequencing. The Nkx2.2TNmut
exchange vector was used to perform RMCE using mouse
embryonic stem cells containing the Nkx2.2LCA allele. A dual,
positive-negative selection strategy was used to identify clones
that had undergone cassette exchange (Chen et al. 2011), which
were then confirmed by DNA PCR. Positive clones were further
analyzed by Southern blot analysis for the presence of the novel
SalI restriction site. Nkx2.2TNmut/+ embryonic stem cells were
injected into blastocysts obtained from the mating of C57Bl/6
mice, then transferred to pseudopregnant C57Bl/6 mice. Male
chimeras were bred to C57Bl/6J female mice, and agouti off-
spring were PCR-genotyped using Nkx2.2 allele-specific primers
that distinguish between the wild-type and Nkx2.2TNmut allele
(Fig. 1B): oKL6 (FWD, wild type), GTCAAGGACATCTTGG
ACCTTCCG; oKL1 (FWD, Nkx2.2TNmut), TTTGCAGCAGCGG
CAATC; and oKL5 (REV, wild type and Nkx2.2TNmut), ATCCGG
GATGGGACTTGGACATTA. The FRT-flanked hygromycin cas-
settewas subsequently removed bymating to FlpEmice (Rodriguez
et al. 2000). All procedures to generate the Nkx2.2TNmut mice
were approved by the Vanderbilt University Animal Care and
Use Committee.
Animal maintenance
All mice weremaintained on a Swiss Black (Taconic) background
and housed and treated according to the Columbia University
Institutional Animal Care and Use Committee approval pro-
tocol. Genotyping of Nkx2.2TNmut mice and embryos was
performed using Nkx2.2 allele-specific primers (described above).
Genotyping of Arxflox/flox mice, Ins:Cre mice, Rosa26:Tomato
mice, Rosa26:LacZ mice, and Pdx:CreER mice was performed as
previously described (Herrera 2000; Gu et al. 2002; Marsh et al.
2009; Madisen et al. 2010).
Immunohistochemistry
Tissues were fixed in 4%PFA for 4 h or overnight, washed in cold
PBS, incubated in 30% sucrose, and cryopreserved. Immunoflu-
orescence was performed on 7 mM sections. See Supplemental
Table 1 for a list of antibodies used. Fluorescent images were
obtained with a Nikon Eclipse 80i microscope, Q-image camera,
and ImagePro software (Media Cybernetics). Confocal images
were captured using a Zeiss LSM 510 upright (pinhole = 1).
For quantification purposes, stained cells were counted manu-
ally on every fourth section (E12.5 and eE13.5) and every eighth
section (E15.5) throughout the entire pancreas for the wild type
(n = 3) and mutant (n = 3). For animals at E18.5, the number
of stained cells, which were counted on every eighth section,
was divided by total pancreas area. All values are expressed as
mean 6 SEM. Statistical analysis was performed using a two-
tailed Student’s unpaired t-test. Results were considered signif-
icant when P < 0.05.
RNA analysis
Total RNA was isolated from whole pancreatic tissue from the
respective embryonic ages (RNeasy, Qiagen), and cDNA was
prepared using the SuperScript III kit (Invitrogen) and random
hexamer primers. Quantitative PCR was performed using 200 ng
of cDNA, PCR master mix (Eurogentec), and TaqMan probes
(ABI Assays on Demand). See Supplemental Table 2 for a list of
primers used. All genes were normalized to Cyclophilin B and
were quantified with ABI prism software. An n$ 4 was obtained
for all mouse populations. All values are expressed as mean 6
SEM. Statistical analysis was performed using a two-tailed
Student’s unpaired t-test. Results were considered significant
when P < 0.05.
ChIP
a-TC1 and b-TC6 cells were grown to ;80% confluency in a
15-cm culture dish and were formaldehyde-cross-linked accord-
ing to the ChIP-IT Express kit (Active Motif). Cross-linked
chromatin was fragmented by sonication using a Diagnode
BioRupter (8 min to 30 sec on/off). Three micrograms of mouse
a-Nkx2.2 (Developmental Studies Hybridoma Bank [DSHB]),
Papizan et al.
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rabbit a-TLE3 (Santa Cruz Biotechnologies), rabbit a-HDAC1
(Santa Cruz Biotechnologies), rabbit a-Nkx6.1 (Beta Cell Biology
Consortium), or mouse a-IgG (AbCam) was added to the sheared
chromatin. The antibody/chromatin complexes were left to
rotate end to end overnight at 4°C. Antibody/chromatin com-
plexes were pulled down using ChIP-grade protein G magnetic
beads (Cell Signaling). Chromatin was washed, eluted, and
reverse-cross-linked, followed by protease treatment. Chromatin
fragments were then analyzed by quantitative PCR using SYBR
Green fluorescence with the following primers: Arx (FWD),
TCCTCCACCATTTGAGGGTA; and (REV), GCAACTTGAGG
GGGTACAGA. All values are expressed as mean 6 SEM. Statis-
tical analysis was performed using a two-tailed Student’s unpaired
t-test. Results were considered significant when P < 0.05.
Coimmunoprecipitation and Western
Nuclear extraction was performed on excised pancreata from
P0 mouse pups using the Nuclear Complex Co-IP kit (Active
Motif). Nuclear extract was pooled from five wild-type or five
mutant animals. One-hundred-fifty micrograms of nuclear
extract and 5 mg of rabbit anti-TLE3 (Santa Cruz Biotechnol-
ogies), rabbit a-Dnmt3a (Santa Cruz Biotechnologies), mouse
a-Nkx2.2 (DSHB), or rabbit anti-IgG (Chemicon) were incu-
bated overnight at 4°C, rotating end to end. Protein/antibody
complexes were pulled down using protein G DynaBeads
(Invitrogen). Protein/antibody complexes were washed, eluted,
and run on a NuPAGE Novex 10% Bis-Tris gel (Invitrogen).
Proteins were transferred onto a nitrocellulose membrane
(GE Healthcare) and probed using mouse anti-Nkx2 or rabbit
a-Dnmt3a. For immunoprecipitation control, the membrane
was stripped, washed, and reprobed with the antibody that was
used for the initial immunoprecipitation.
Luciferase assays
To generate the Arx-Luciferase reporter, a 2.5-kb fragment of the
Arx genomic region upstream of the transcriptional start site was
PCR-amplified from mouse tail genomic DNA using the follow-
ing primers: oRS18 (FWD), ACGCGTTGCACCTCCCCCTTTA
CAGTGGGTGATTA; and oRS19 (REV), AGATCTTGGGCT
CAGAGAGCGGACCT. MluI and BglII sites were incorporated
into the 59 and 39 ends, respectively, to facilitate cloning into the
pGL3 basic promoter-less luciferase reporter vector using MluI
and BglII cloning sites. The resulting plasmid was verified by
DNA sequencing. Luciferase assays were performed in aTC1 and
bTC6 cell lines using the Dual-Luciferase Reporter Assay
System (Promega) as described previously (Hill et al. 2010).
Tamoxifen treatment in Pdx:CreER;R26R:Tomato mice
Pdx:CreER was induced with a 5-mg intraperitoneal injection of
tamoxifen (Sigma) in 3-wk-old mice every 48 h for 4 d. On the
fifth day, pancreata were harvested and fixed in paraformalde-
hyde, as described above, and immunostained for indicated
hormones.
In vitro siRNA-mediated knockdown
Knockdown ofDnmt3a,Arx, andDnmt3a+Arx inMin6 cells was
performed by transfection of specific-targeting small inhibitory
RNAs or scrambled controls (Dharmacon Research, Inc.) using
Lipofectamine-2000 (Invitrogen), according to the manufac-
turer’s instructions, in OPTI-MEM medium. Min6 cells were
transfected with appropriate siRNAs or scrambled controls every
3 d (average transfection efficiency, 65%–80%), and samples
were harvested at 4 d post-transfection, as indicated. RNA was
isolated from cells using TRI Reagent (MRC) and treated with
DNase (Ambion) according to the manufacturers’ instructions.
One microgram of RNA was used for preparation of single-
stranded cDNA using SuperScript III reverse transcriptase
(Invitrogen) by the oligodT primingmethod. Real-time RT–PCRs
were performed using the Fast SYBR Green Master Mix (Applied
Biosystems) and the 7900HT Fast Real-Time PCR equipment
(Applied Biosystems). The expression levels of each transcript
were normalized to the housekeeping gene Cyclophilin. Each
real-time PCR experiment shown is a representative from at
least three independent experiments. Primers for RT–PCR are
listed in Supplemental Table 2.
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Supplemental figure 1. Nkx2.2TNmut/TNmut mice are hyperglycemic. Fed blood glucose levels 
(A-C) (n = 3-6). Neither male nor female Nkx2.2TNmut/TNmut mice are diabetic at weaning (3 
weeks old) (A). Male Nkx2.2TNmut/TNmut mice become diabetic shortly after weaning (3.5 weeks 
old) (B). Both male and female Nkx2.2TNmut/TNmut mice are diabetic by 7 weeks old (C). 
Characterization of insulin, glucagon and ghrelin expressing cells in Nkx2.2TNmut/TNmut mice (n = 
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Supplemental figure 2. Beta cells do not undergo apoptosis and α cells do not proliferate in 
Nkx2.2TNmut/TNmut mice. Immunofluorescence showing exclusive staining of insulin and 
caspase3 at e12.5, a time point just prior to detection of changes in beta cell numbers (A,B). At 
e15.5, when beta cell numbers are significantly decreased in Nkx2.2TNmut/TNmut mice, caspase3 
staining is still excluded from beta cells (C,D). Insets in (B,D) show caspase3 staining in liver 
tissue present in the same tissue section. Immunofluorescence showing exclusive staining of 
glucagon and PHH3 at e12.5, prior to changes in alpha cell numbers (E,F). At e15.5, as alpha 
cells are beginning to increase in the Nkx2.2TNmut/TNmut mice, PHH3 staining is not detected in 
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Supplemental figure 3. MafB localization in Nkx2.2TNmut/TNmut mice. MafB expression is 
restricted to glucagon expressing cells (A,B) and excluded from insulin expressing cells (C,D) in 







































GENESDEV/2011/173039 Papizan et al., Supplemental figure 3 
   
54 
Supplemental figure 4. a cells acquire beta cell marker expression as beta cells 
transdifferentiate to alpha cells. The R26Rtomato reporter expression under the control of 
Ins:Cre, is restricted to beta cells (A). Using the R26RLacZ reporter, beta cell-derived α cells can 
be detected in Nkx2.2TNmut/TNmut mice (B,C). By e15.5, as alpha cell numbers are beginning to 
increase, Nkx6.1 is misexpressed in alpha cells of the Nkx2.2TNmut/TNmut mice (D,G). At P0, the 
beta cell markers MafA (E,H) and Pdx1 (F,I)  are commonly found in alpha cells of 
Nkx2.2TNmut/TNmut mice. Appoximately 2.5% of glucagon expressing cells are labeled with the 
Tomato reporter at P0 (J). Although there is an increase in ghrelin expression and cell number, 
lineage tracing using Ins:Cre confirms that the increased ghrelin cells are not beta cell-derived 
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Supplemental figure 5. Beta-to-alpha cell reprogramming continues postnatally. 3 week old 
TN/TN;Pdx1:CreER;TOM mice show no Tomato expression in the absence of Tamoxifen 
treatment (A). Upon Tamoxifen treatment, Tomato expression is restricted from alpha cells in 3 
week old TN/+;Pdx1:CreER;TOM mice (B). However, Tamoxifen treatment induces Tomato 
expression in glucagon expressing cells in 3 week old TN/TN;Pdx1:CreER;TOM mice (C) (n = 
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Supplemental figure 6. Arx promoter conservation and regulation. The Arx promoter 
contains a highly conserved Nkx2.2 binding site at -1.4 kb (A). Coimmunoprecipitation analysis 
showing interaction between Nkx2.2 and Dnmt3a in WT and Nkx2.2TNmut/TNmut mice (B). 
Chromatin immunoprecipitation demonstrates an enrichment of Nkx6.1 on the Arx promoter 
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Supplemental figure 7. beta cell-targeted loss of Arx. Wild type mice with beta cell-specific 
loss of Arx form normal islets (A) (n = 3). Real-time RT-PCR analyses comparing the transcript 
levels of Dnmt3a, Pdx1, Pax4, Insulin (Ins), Glucagon (Glu), MafB and Arx in Min6 cells, after 4 
days of transfection with scrambled (Scr), Dnmt3a, Arx or Dnmt3a+Arx siRNAs, showing a 
requirement for Arx in cell fate conversion upon loss of Dnmt3a (n=3) (B). *: p<0.05 vs Scr 
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Supplementary Table 1 
Primary Antibody Dilution Source 
Rabbit D-glucagon 1:1000 Phoenix Pharmaceuticals 
Guinea pig D-glucagon 1:1000 Linco 
Guinea pig D-insulin 1:1000 Linco 
Rabbit D-ghrelin 1:500 Phoenix Pharmaceuticals  
Rabbit D-PP 1:500 Linco 
Rabbit D-somatostatin 1:500 Phoenix 
Rabbit D-Pdx1 1:1000 Chemicon 
Rabbit D-MafA 1:500 Bethyl 
Rabbit D-MafB 1:500 Bethyl 
Rabbit D-Nkx6.1 1:500 BCBC 
Rabbit D-Arx 1:500 K. Miyabayashi, Fukuoka, 
Japan 
Rabbit D-caspase3 1:250 Cell Signaling 
Rabbit D-phospho-histone-
H3 
1:500 Millipore  
Secondary Antibody Dilution Source 
Cy2 donkey D-guinea pig 1:250 Jackson ImmunoResearch 
Cy3 donkey D-rabbit 1:250 Jackson ImmunoResearch 
Cy2 donkey D-rabbit 1:250 Jackson ImmunoResearch 
Cy3 donkey D-guinea pig 1:250 Jackson ImmunoResearch 
Cy5 donkey D-guinea pig 1:250 Jackson ImmunoResearch 

 
























Gene Sybr green FWD Sybr green REV 




MafA CCTCTAGAGGAAGCCGAGGAA CCTCCCCCAGTCGAGTATAGC 
Dnmt3a AACGGAAACGGGATGAGTG ACTGCAATTACCTTGGCTTTCT 
Pdx1 GAAATCCACCAAAGCTCACG CGGGTTCCGCTGTGTAAG 
Pax4 TCCCAGGCCTATCTCCAAC TATGAGGAGGAAGCCACAGG 
Ins1 GCAAGCAGGTCATTGTTTCAAC AAGCCTGGGTGGGTTTGG 
MafB CAACAGCTACCCACTAGCCA GGCGAGTTTCTCGCACTTGA 
Arx TTCCAGAAGACGCACTACCC TCTGTCAGGTCCAGCCTCAT 
Glucagon CATTCACCAGCGACTACAGCAA TCATCAACCACTGCACAAAATCT 
Cyclophilin GTTGGCCAGGCTGGTGTCCAG CTGTGATGAGCTGCTCAGGGTGG

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CHAPTER 3 
TRANSCRIPTIONAL PROFILING OF NKX2.2TNmut/TNmut AND 
NKX2.2TNmut/TNmut;INS:CRE;ARXFL/FL PANCREAS 
Microarray analysis was performed by the University of Pennsylvania School of Medicine’s 
IDOM-DRC Functional Genomics Core. James Papizan generated all other data.  
Abstract 
The Nkx2.2TNmut/TNmut mice are hyperglycemic and exhibit defects in islet cell fate specification 
and beta cell maintenance. The phenotype, in part, is due to the de-repression and ectopic 
expression of Arx in beta cells, resulting in beta-to-alpha-like cell reprogramming. Interestingly, 
several aspects of the Nkx2.2TNmut/TNmut islet phenotype cannot be rescued by the beta-cell-
specific Arx deletion, and the mice remain hyperglycemic due to defects in beta cell formation 
and function. To identify the dysregulated genes responsible for the persistent beta-cell 
phenotype in the Nkx2.2 TNmut/TNmut;Ins:Cre;Arxfl/fl mice, we compared global gene expression 
analysis of the pancreata of wildtype, Nkx2.2TNmut/TNmut, and Nkx2.2 TNmut/TNmut;Ins:Cre;Arxfl/fl 
(i.e., Arx rescued) neonatal mice. The data generated from this analysis identified many genes 
whose altered expression is independent of ectopic Arx expression, and which have diverse roles 
ranging from chromatin remodeling to metabolic functioning. This information provides insight 
into the molecular mechanisms by which Grg-mediated Nkx2.2 function normally regulates beta 
cell specification, maturation and function.   
Introduction 
Pancreogenesis is a tightly controlled process that requires the correct spatiotemporal regulation 
of many genes. In regenerative medicine, many investigators are drawing on the knowledge 
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gained from pancreas development studies that have begun to characterize the gene regulatory 
networks required for proper allocation of differentiated endocrine cell types, in an attempt to 
treat diabetes with stem cell-derived beta cell replacement therapy. Over the past twenty years, a 
great amount of research has begun to unravel the transcriptional networks required for 
pancreatic endocrine cell lineage determination, which has directly contributed to enhancements 
in stem cell-derived beta cells. However, functional ES cell-derived beta cells have yet to be 
produced. The most recent in vitro protocol yields only a small percentage of insulin positive 
cells, which are not glucose responsive. Additionally, many cells generated were poly-hormonal, 
and the majority were ghrelin positive (D'Amour et al., 2006). This is particularly interesting 
when considering the phenotypes of the Nkx2.2 null mice, which have a full replacement of beta 
cells with ghrelin-positive epsilon cells (Prado et al., 2004), and the Nkx2.2-SD mutant mice, 
which exhibit many poly-hormonal cells (J. Levine and L. Sussel, unpublished data). This 
suggests that transcription factors play a pivotal role in determining endocrine cell identity, and 
that the expression of these factors is not optimal in the ES-cell derived beta cells. Thus, fully 
understanding the consequences of a transcription factor’s action, i.e., stage and cell type 
expression, activator/repressor functions and locus-specific co-regulatory recruitment, will 
greatly enhance our knowledge of endocrine cell ontogeny at a molecular level and assist in 
enhancing ES-cell-based differentiation protocols.      
To identify dysregulated genes in the Nkx2.2TNmut/TNmut mice, we generated a microarray data set 
from P0 pancreatic RNA. We have previously demonstrated that Arx ectopic expression in 
Nkx2.2TNmut/TNmut mice causes a beta-to-alpha-like-cell transdifferentiation, and beta-cell-specific 
loss of Arx (Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl) was sufficient to rescue this reprogramming event; 
however, Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice retained a beta-cell specification defect and 
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remained hyperglycemic. Our microarray analysis identified several intriguing genes involved in 
very disparate aspects of cell biology, including chromatin remodeling and metabolic control, 
that are altered in Nkx2.2TNmut/TNmut mice and not rescued in the Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl 
mice. The data presented here will assist in the identification of novel mediators of endocrine cell 
specification and metabolic function.  
Results 
The purpose of this analysis was to identify genes that are changed in Nkx2.2TNmut/TNmut mice and 
not rescued in the Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice, which could identify novel 
transcriptional pathways regulated by Nkx2.2. These genes would most likely be responsible for 
the pancreatic defects that persist in Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice and are independent 
of Arx and the beta-to-alpha transdifferentiation phenomenon. To identify these genes, we 
isolated P0 pancreatic RNA from wild type, Nkx2.2TNmut/TNmut, and 
Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice (n = 3 per genotype) for microarray analysis. Using a 
minimum fold cutoff of 1.5, our microarray analysis identified 9,924 genes with altered 
expression in Nkx2.2TNmut/TNmut mice compared to wild type. When Nkx2.2TNmut/TNmut mice were 
compared to Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice, there were 12,076 changed genes (Figure 
1A). The majority of these genes were changed in the opposite direction, suggesting beta-cell-
specific loss of Arx rescued many of the changes in gene expression seen in Nkx2.2TNmut/TNmut 
mice (Figure 1B). Accordingly, only 278 genes remained upregulated in the 
Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice when compared to wild type. Our studies identify 
Prominin-2, Irs4 and Rbbp4 as significantly upregulated in Nkx2.2TNmut/TNmut mice and not 
rescued with beta-cell-specific deletion of Arx. We initially chose to focus on these three genes, 
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since they are potentially involved in processes that are important for formation and maturation 
of beta cells, including chromatin remodeling, cell-cell communication and metabolic functions.  
Prominin-2 
Prominin-2 is a cholesterol-binding pentaspan membrane glycoprotein that is structurally related 
to Prominin-1 (CD-133). Prominin-1 has garnered much interest, as it has been described to be 
an important cell surface marker capable of identifying and isolating stem cells from the kidney 
and the haematopoietic and central nervous systems (Bitan et al., 2005; Bussolati et al., 2005; 
Lee et al., 2005). Recent studies demonstrate that prominin-1 is expressed within the pancreatic 
acinar rosettes, but is excluded from a Ngn3+ progenitor populaiton, suggesting that prominin-1 
is most likely not a marker for endocrine progenitors (Hald et al., 2012) While prominin-1 is 
expressed in both epithelial and non-epithelial cells, prominin-2 is restricted to epithelial cells 
and is expressed in the kidney tubules, pancreas and abundantly throughout the digestive tract 
(Florek et al., 2007). Other than a cholesterol-binding, membrane protein, no clear functional 
role has been described for prominin-2.  
Our microarray identified prominin-2 as having an 18-fold increased expression in wild-type 
mice compared to Nkx2.2TNmut/TNmut mice. This change in expression was unaltered in the 
Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice, demonstrating prominin-2 regulation is independent of 
Arx and may be a direct target of Nkx2.2. Prominin-2 expression was unchanged at e14.5 (Figure 
4A), a time when the first changes are seen in hormone expression in the Nkx2.2TNmut/TNmut mice; 
however, by P0 prominin-2 was significantly elevated, in congruence with the microarray 
findings (Figure 4B). This suggests that prominin-2 is not involved in the immediate and direct 
effects of the Nkx2.2TNmut/TNmut early phenotype, since its expression is unchanged during a time 
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when abnormalities are occurring in the Nkx2.2TNmut/TNmut  mice, but rather could be eliciting 
later defects in beta cell function.  
In silico analysis of the prominin-2 promoter identified a small area of conservation about 1.8 kb 
upstream of the TSS containing the lower affinity Nkx2.2 core motif GAGT (opposed to AAGT) 
(Figure 5A), which has been described previously (Hill et al., 2011). Furthermore, this site was 
predicted to be an Nkx2.2 binding site by PBM mapping analysis (personal communication, 
Jonathon Hill). To test whether Nkx2.2 directly binds this region of prominin-2, I performed 
ChIP and qRT-PCR with primers surrounding the putative Nkx2.2 binding motif, which revealed 
a strong enrichment of Nkx2.2. As a positive and negative control, Nkx2.2 ChIP is shown using 
primers specific to Arx and Gapdh, respectively (Figure 5B). This finding suggests that 
prominin-2 is a direct target of Nkx2.2, but since its expression is unaltered at e14.5 in the 
Nkx2.2TNmut/TNmut mice, it may not be responsible for the early specification defects observed at 
that time.  
Insulin receptor substrate 4 (Irs4) 
IRS proteins are major docking proteins of both the IGF-1 and insulin receptors and undergo 
rapid tyrosine phosphorylation upon ligand binding (Kahn et al., 1993). Most of insulin’s actions 
are propagated through tyrosine phosphorylation of the IRS proteins 1-4. While functions for all 
IRS proteins have been described, most of the insulin-induced anabolic and nutritional 
homeostatic responses are mediated through IRS1 and 2 (White, 2003). Irs4 was discovered by 
anti-phosphotyrosine affinity chromatography following insulin treatment of Hek293 cells 
(Lavan et al., 1997). Its tissue distribution was detected by RT-PCR of its isolated message and 
revealed strong expression in skeletal muscle, brain, heart, liver and kidney, and very weak 
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expression was detected in the pancreas (Fantin et al., 1999). In accordance with Irs1 and 2 being 
the main mediators or insulin action, Irs4-/- mice have a very subtle phenotype, exhibited by a 
slightly smaller body size and lower glucose levels in the fed and fasted state. While glucose 
tolerance tests in the Irs4-/- mice were moderately impaired, suggesting problems with glucose 
clearance (Fantin et al., 2000), functional studies have suggested that Irs4 antagonizes insulin-
stimulated Irs1 and 2 activity (Tsuruzoe et al., 2001), which is consistent with the reduced fed 
and fasted glucose levels in the Irs4-/- mice, but inconsistent with the impaired glucose tolerance 
tests.  
Irs4 was upregulated 18 fold in the Nkx2.2TNmut/TNmut mice and remained elevated in the 
Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice, suggesting the upregulation of Irs4 is independent of Arx. 
Interestingly, Irs4 has previously been predicted by PBM mapping and validated by EMSA and 
ChIP as being a direct target of Nkx2.2 in a pancreatic beta cell line (Hill et al., 2011). These 
data suggest that the Nkx2.2/Grg3 repressor complex is required to repress Irs4 in pancreatic 
beta cells to allow for proper insulin receptor/Irs1-2 activity.  
Retinoblastoma binding protein 4 (Rbbp4) 
Retinoblastoma binding proteins are ubiquitously expressed nuclear proteins and were originally 
identified as the major interacting proteins with retinoblastoma (Qian et al., 1993). Based on the 
fact that Rbbps interact with the core histones H2A and H4 and are part of large complexes 
involved in modifying core histones and remodeling nucleosome structure (Verreault et al., 
1998), Rbbps are believed to function as bridges that link histone modifying enzymes with their 
targets. Rbbp4, also known as RbAp4, is a core component of several histone 
modifying/nucleosome remodeling complexes such as NuRD, PRC2 and Sin3. Our microarray 
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identified Rbbp4 having a 33-fold increased expression in the Nkx2.2TNmut/TNmut mice compared 
to wild type, and this expression was only partly rescued in the Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl 
mice.  Additionally, the Champion ChIP Transcription Factor Search Portal, which is based on 
SABioscience’s proprietary database, DECODE, predicted an Nkx2.2 binding motif upstream of 
the Rbbp4 transcriptional start site. The Nkx2.2 binding site is also within a CpG island, an 
epigenetic signature that has been associated with Nkx2.2 binding (Papizan et al., 2011) (Figure 
3A). Furthermore, the Nkx2.2 motif is a predicted binding site with a score of .32 when analyzed 
with PBM-mapping (personal communication, Jonathon Hill) (Hill et al., 2011).  
To determine if Nkx2.2 directly binds to the Rbbp4 promoter, and if Grg3 is also recruited, I 
performed a ChIP analysis in beta TC6 cells with antibodies against Nkx2.2 or Grg3. I 
subsequently amplified the associated DNA with 3 sets of primers spanning a 700 bp region 
(Regions 1-3). The ChIP analysis suggests that Nkx2.2 and Grg3 are both present on the Rbbp4 
promoter in a beta TC6 cell line (Figure 3B). However, I was unable to validate the microarray 
findings with qRT-PCR at e14.5 or P0 (Figure 2A,B), which could be attributed to differences in 
primer sets used in the array versus the set I generated. Accordingly, the Agilent microarray uses 
two probes to assess Rbbp4 expression: probe A_52_P424767 shows the increase in expression, 
while probe A_51_P307325 shows no change. While the ChIP analysis suggests that Nkx2.2 and 
Grg3 are binding the Rbbp4 promoter and perhaps repressing its transcription in beta cells, it will 
be useful to generate primers similar to the microarray probe used to identify the change in 
Rbbp4 expression to confirm the change with qRT-PCR.    
Discussion 
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We have previously determined that the Nkx2.2 TN mutation de-represses Arx in beta cells and 
results in beta-to-alpha cell reprogramming. Beta cell-specific deletion of Arx in the 
Nkx2.2TNmut/TNmut background prevented cellular reprogramming, but was insufficient to rescue 
the beta cell specification defect and beta cell function, suggesting other Nkx2.2/Grg-dependent 
genes are responsible for these functions. To identify genes important for beta cell specification 
and function, we compared gene expression of Nkx2.2TNmut/TNmut mice with Arx-rescued mice. 
The microarray analysis identified many genes that are affected by the Nkx2.2 TN mutation, 
many of which are involved in pancreas development, but also genes important in metabolic 
pathways, including insulin and growth factor signaling. Notably, Ingenuity Pathway Analysis 
identified the top functional pathways that were altered in the Nkx2.2TNmut/TNmut mice were 
involved in the hematological system, immune cell trafficking, cell-to-cell communication and 
inflammatory responses (Figure 1B). Given that the Nkx2.2TNmut/TNmut mice have lost the Grg-
mediated Nkx2.2 repressor capacity, and most of the effectors of these pathways are 
downregulated, the changes in these functional pathways may be viewed as secondary effects.   
The primary transition of pancreas development, which occurs from e9.5 to e12.5, involves 
thickening of the endoderm, proliferation of pancreatic progenitors and branching 
morphogenesis. The onset of the secondary transition at e12.5-13 marks the beginning of a major 
wave of endocrine cell differentiation, primarily that of beta cells. The first changes in the 
Nkx2.2TNmut/TNmut mice are seen at e13.5 with decreases in insulin and increases in ghrelin 
expression. Increases in Arx are not observed until e15.5, with subsequent changes in glucagon 
expression occurring at e18.5. Interestingly, deletion of Arx prevents the beta-to-alpha cell 
transdifferentiation, but the beta cell population is not fully restored. Future experiments will 
focus on identification of changes in the expression of genes occurring at or before e13.5 since 
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genes whose expression is changed at this time could be responsible for the primary effects 
causing the beta-to-epsilon cell fate shift. Unfortunately, it was difficult to obtain enough quality 
RNA at e13.5 for the microarray; instead we chose to assess gene expression at P0, reasoning 
that these candidate genes will still be changed at this time point.  
The fact that Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice retain beta cells, although at a lower mass 
compared to wild type, and remain hyperglycemic, suggests that the beta cells that are formed 
are dysfunctional. Mice lacking the insulin receptor specifically in the beta cells exhibit 
impairments in insulin secretion and glucose tolerance but maintain normal beta cell 
development (Kulkarni et al., 1999). Additionally, compound beta cell-specific loss of the insulin 
and IGF1 receptor suggests that insulin plays a major roll in beta cell proliferation (Ueki et al., 
2006). Irs4 has been shown to antagonize insulin and IGF1 signaling by impairing IRS1 and 2 
activity (Tsuruzoe et al., 2001). Thus, the increase in Irs4 expression in the Nkx2.2TNmut/TNmut 
mice, which is not rescued in the Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice, may cause functional 
defects in the beta cell similar to those observed in beta cell-specific IR and/or IFG1 knockout 
mice.  
Hald et al. have shown that prominin-1 is expressed in the acinar rosettes and restricted from the 
Ngn3+ endocrine precursor population (Hald et al., 2012). However, an inspection of pancreatic 
prominin-2 protein expression has yet to be thoroughly investigated. If the Nkx2.2/Grg3 complex 
were directly repressing prominin-2 in the endocrine population, the TN mutation would 
presumably be responsible for the elevated prominin-2 expression in the Nkx2.2TNmut/TNmut mice. 
Being a pentaspan membrane protein, the de-repression of prominin-2 in the endocrine cells 
could then wreak havoc with the appropriate cell-cell interactions/communications that may be 
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required for proper endocrine cell formation and maintenance. Therefore, functional and 
immunohistochemical analyses of prominin-2 throughout pancreatic development is warranted.   
The effects due to dysregulation of Irs4, Rbbp4 or Prominin-2 indiviually is unlikely to account 
for beta cell specification defects and dysfunction in the Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice. 
But the combinatorial action resulting from their dysregulation could interfere with both beta cell 
specification and function. These data presented here highlight the many roles Nkx2.2 may play 
in endocrine cell ontogeny, and may lead to new therapeutic targets of diabetes and a better 
understanding of stem cell-directed differentiation protocols.  
Materials and Methods 
RNA isolation, expression and microarray 
Total RNA was isolated from whole pancreatic tissue from e14.5 or P0 mouse pups (RNeasy, 
Quiagen), and cDNA was prepared using the SuperScript III kit (Invitrogen) and random 
hexamer primers. Quantitative PCR was performed using 200 ng cDNA and SYBR Green 
fluorescence with the following primers: Rbbp4 (FWD) – TCTGTTTGGGTCAGTTGCTG, and 
(REV) – AACTGAGTGGCTTGGTTTGG; Prominin2 (FWD) – 
ACAACTTTTCCATATCCCCAGG, and (REV) – ACAAGGACAAAGGACAGGAAG; and 
CycloB (FWD) – GCAAAGTTCTAGAGGGCATGGA, and (REV) – 
CCCGGCTGTCTGTCTTGGT. The single color Agilent whole genome array analysis was 
performed by the University of Pennsylvania School of Medicine’s IDOM-DRC Functional 
Genomics Core using P0 whole pancreatic RNA.  
Chromatin Immunoprecipitation 
   
73 
Expression vectors containing 3Xmyc-Nkx2.2 cDNA or Grg3 cDNA were transfected into 
betaTC6 cells using X-tremeGENE HP (Roche) according to the provider’s protocol. Chromatin 
was prepared using the ChIP-IT express kit (Active Motif). Immunoprecipitation was performed 
using the isolated chromatin diluted in ChIP dilution buffer (16.7 mM Tris-HCl pH 8.1, 167 mM 
NaCl, 0.01% SDS, 1.1% Triton-X 100) with 5 ug of mouse anti-myc (Kelloff et al.) or rabbit 
anti-TLE3 M201X (Santa Cruz Biotechnology) antibody while rotating overnight at 4° C. The 
following day antibody/chromatin complexes were pulled down using ChIP grade protein G 
magnetic beads (Cell Signaling). The beads were washed once with 1 mL each of the following 
wash buffers in order: TSE I (20 mM Tris-HCl (ph 8.1), 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 
1% Triton X-100); TSE II (20 mM Tris-HCl (pH 8.1), 500 mM NaCl, 2 mM EDTA, 0.1% SDS, 
1% Triton X-100); ChIP Buffer III (10 mM Tris-HCl (pH 8.1), 0.25 M LiCl, 1 mM EDTA, 1% 
NP-40, 1% deoxycholic acid); TE (10 mM Tris-HCl (pH 8.1), 1 mM EDTA). The 
antibody/chromatin complexes were eluted from the beads with the addition of 100 uL of freshly 
made elution buffer (1% SDS, 0.1 M NaHCO3) and allowed to rotate at room temperature for 15 
minutes. 4 uL 5 M NaCl was added to the eluate and incubated at 65° C overnight. The 
following day 4 uL 1 M Tris-HCl (pH 7.5), 4 uL 0.5 M EDTA and 1 uL 10 mg/mL proteinase K 
were added and allowed to incubate at 37° C for 1 hour. Samples were then purified using the 
QIAquick PCR purification kit (Qiagen). Quantitative analysis of ChIP products was performed 
using 2 uL of PCR purified ChIP DNA and SYBR Green fluorescence with the following 
primers: Rbbp4 region 1 (FWD) – GACCAATGAGAAAGCGCGGGT, and (REV) 
AAGTCTCCGGACTGTGGTGGG; Rbbp4 region 2 (FWD) – CCACCCCCCACCACAGTCCG, 
and (REV) – TCGCTACCCTGAGGGAGTTGTCAGC; Rbbp4 region 3 (FWD) – 
GCTGACAACTCCCTCAGGGTAGCGA, and (REV) – 
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AGGGAGTCAGTTAAAAGACGCCACCTTGAAT; Prominin2 (FWD) – 
AGTTCTCCTAGAGTTGGGGGTG, and (REV) – CTTCCTCCACATACCAGAGCTGG; 
Gapdh (FWD) – CTCCACGACATACTCAGCACC, and (REV) – 
TCAACGGCACAGTCAAGGC.  
 
Figure 1: Global gene expression changes in P0 pancreatic RNA. A) Gene expression 
changes in wild type vs. Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl (ARX-WT, top row), wild type vs. 
Nkx2.2TNmut/TNmut (TN-WT, middle row), and Nkx2.2TNmut/TNmut vs. 
Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice (ARX-TN, bottom row). B) Ingenuity Pathway Analysis 
of top functional pathways altered in Nkx2.2TNmut/TNmut mice. Blue coloring indicates 
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indicates upregulated pathways in Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl compared to 
Nkx2.2TNmut/TNmut mice (Boden et al.).    
 
 
Figure 2: qRT-PCR confirmation of gene expression changes in Nkx2.2TNmut/TNmut mice. A) 













Figure 3: Nkx2.2 binds the prominin-2 promoter in beta-TC6 cells. A) In silico analysis of 
the prominin 2 gene. The Nkx2.2 core motif is highlighted in yellow (inset). B) ChIP analysis 
demonstrating Nkx2.2 is highly enriched on the prominin 2 promoter in beta TC6 cells. Nkx2.2 
enrichment on Arx is shown as a positive control and gapdh as a negative control. The primers 
used for qRT-PCR analysis of ChIP for prominin 2 are shown as a PCR amplicon above the 










Figure 4: Nkx2.2 and Grg3 bind the rbbp4 promoter in beta-TC6 cells. A) In silico analysis 
of the rbbp4 promoter. B) ChIP analysis demonstrating Nkx2.2 and Grg3 are highly enriched on 
the rbbp4 promoter in beta TC6 cells. The primers used for qRT-PCR analysis of ChIP for 
region 1 are shown as a PCR amplicon above the conservation map in (A). Regions 2-3 are 









Figure 5: qRT-PCR confirmation of gene expression changes in Nkx2.2TNmut/TNmut mice. A) 
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CHAPTER 4 
SERINE PHOSPHORYLATION REGULATES NKX2.2 FUNCTION 
James Papizan generated all data presented in this chapter   
Abstract 
Nkx2.2 is expressed in multiple cell types and has the ability to activate and repress gene activity 
(Anderson et al., 2009; Papizan et al., 2011; Raum et al., 2006). In order for Nkx2.2 to properly 
regulate its target genes in a spatiotemporal manner, a high degree of regulation must be in place 
for correct cofactor interaction and DNA binding. Many factors employ post-translational 
modifications (PTMs) as a mechanism to regulate their function. In such cases, the PTM acts as a 
binary switch that dictates cofactor binding. Here, we investigate the possibility of PTMs as a 
mechanism by which Nkx2.2 protein can acquire the ability to differentially interact with 
cofactors and regulate gene expression in a spatial context. Nkx2.2 has highly conserved serine 
and lysine residues, which based on bioinformatic PTM prediction algorithms, are predicted to 
be phosphorylated or acetylated, respectively. Here, I demonstrate that mutations that alter the 
phosphorylation status of Nkx2.2 serine residues cause changes in the recruitment of cofactors to 
Nkx2.2 regulatory elements, and I show these changes are associated with alterations in the 
epigenetic signature. These findings highlight the importance of PTMs in regulating Nkx2.2 in 
vitro activities and warrant further investigations into how they might affect in vivo Nkx2.2 
function, which enzymes are responsible for the modifications, and how these modifications are 
temporally regulated during pancreas development.  
 
Introduction 
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Nkx2.2 is a homeodomain-containing protein required for correct pancreatic islet cell 
development (Sussel et al., 1998) and neuronal differentiation (Briscoe et al., 1999). During 
pancreatic development, Nkx2.2 is expressed during the primary transition at e9.5 and becomes 
restricted to alpha, beta and PP cells, and excluded from delta cells. Mice carrying a null 
mutation for Nkx2.2 exhibit a complete absence of beta cells and a drastic reduction in alpha 
cells (Sussel et al., 1998). In place of these cell types, the Nkx2.2-/- islet is populated with 
ghrelin+ epsilon cells (Prado et al., 2004). These data point to a role for Nkx2.2 in specifying and 
maintaining the alpha and beta cell lineages while suppressing the epsilon cell lineage. 
Subsequent studies demonstrated that expression of an Nkx2.2-engrailed fusion repressor 
construct from the Pdx1 regulatory elements was sufficient to partially rescue the Nkx2.2 null 
phenotype, suggesting that Nkx2.2 is functioning as a repressor to suppress the epsilon cell fate, 
while specifying the alpha cell population (Doyle et al., 2007). Interestingly, while some beta 
cells were rescued with Nkx2.2 repressor activity, they lacked mature markers of mature, glucose 
sensing beta cells, i.e., MafA and Glut2, which may reflect the requirement of Nkx2.2 
transcriptional activator functions for the beta cell maturation process. This hypothesis is 
consistent with previous data that demonstrated Nkx2.2 functions as a transcriptional activator of 
important beta cell genes, such as MafA and NeuroD (Anderson et al., 2009; Raum et al., 2006). 
In addition, a recent study using algorithmic predictions identified 111 novel Nkx2.2 binding 
sites in the proximal promoters of 30 genes differentially expressed in wild type and Nkx2.2 null 
pancreas (Hill et al., 2011). These studies highlight the multitude of functions Nkx2.2 must 
execute for proper islet cell development and function, but do not address how Nkx2.2 can 
simultaneously repress and activate different genes in the same cellular context, or how it can 
activate and repress the same gene in different cellular contexts.   
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PTM is mechanism that can provide a layer of regulation in a tissue-, cell- or gene-specific 
context. Several beta cell factors are known to be post-translationally modified, including 
NeuroD phosphorylation, which has been shown to be required for transcriptional activation of 
the insulin gene upon glucose stimulation (Khoo et al., 2003a). NeuroD phosphorylation has also 
been demonstrated to induce its translocation into the nucleus in response to glucose stimulation. 
This subcellular localization is MEK-ERK dependent and is lost when NeuroD serine-274 
(S274) is mutated to an alanine (Petersen et al., 2002). NeuroD phosphorylation can also inhibit 
its activity in neurons. Studies in Xenopus reveal that formation of N-tubulin positive neurons is 
inhibited when GSK3β, a kinase that is presumably responsible for phosphorylating NeuroD 
S274, is overexpressed, and that co-injection of GSK3β and NeuroD mRNAs inhibits ectopic 
neurogenesis, which is induced by NeuroD mRNA alone (Marcus et al., 1998). Collectively, 
these studies suggest that phosphorylation-induced NeuroD activity is cell type specific.  
PTMs of Pdx1, another essential pancreatic transcription factor with multiple functions, include 
phosphorylation, glycosylation and sumoylation (Boucher et al., 2006; Elrick and Docherty, 
2001; Gao et al., 2003; Kishi et al., 2003). Like NeuroD, the majority of Pdx1 phosphorylation is 
glucose-dependent and regulates its interactions between histone deacetylases and histone 
acetyltransferases (Mosley et al., 2004; Mosley and Ozcan, 2004). Recently, Frogne et al. 
provided thorough evidence that the majority of Pdx1 phosphorylation is occurring at serine 61 
(S61) and is not glucose dependent, contrary to other sites of Pdx1 PTMs (Frogne et al., 2012). 
Although a function for S61 phosphorylation was not determined, these studies suggest that Pdx1 
is differentially phosphorylated in response to metabolic changes and other unknown stimuli, 
which alters Pdx1 regulatory activity by way of cofactor exchange (Mosley et al., 2004), 
subcellular localization (Elrick and Docherty, 2001), and DNA binding (Wu et al., 1999).  
   
82 
Here, we sought to determine whether PTMs regulate Nkx2.2 activity in a context dependent 
manner. We demonstrate that Nkx2.2 contains several highly conserved serine and lysine 
residues predicted to be phosphorylated and acetylated, respectively. Point mutations to S11 alter 
the ability of Nkx2.2 to properly recruit cofactors to promoter regions in beta and alpha cell lines. 
These changes are also associated with alterations in the local epigenetic landscape at these 
promoters. Further characterization of phosphorylation-induced Nkx2.2 regulatory activity, and 
the responsible kinase(s) and phosphatase(s), will enhance our understanding of the complexities 
of cell specific gene regulatory events and cell differentiation. These findings could also lead to 
the identification of small molecules that could help promote the differentiation of hES cells 
toward the beta cell lineage.  
Results 
Nkx2.2 is expressed in multiple cell types and has the ability to activate and repress gene activity 
in a context-dependent manner (Anderson et al., 2009; Papizan et al., 2011; Raum et al., 2006; 
Sussel et al., 1998). The observation that ventral nervous defective (Vnd), the Nkx2.2 Drosophila 
homolog is phosphorylated (Zhang et al., 2008), suggests that PTMs might provide an additional 
component of regulation required for context dependent Nkx2.2 activity.  
To determine which amino acid residues are sites of modification, the murine Nkx2.2 peptide 
sequence was subjected to a sequence-based PTM prediction analysis (Blom et al., 1999). 
Multiple serine, threonine and tyrosine residues were predicted to be phosphorylated, but only 
four serine residues reached a score greater than 0.99 (1.0 being the greatest), with S11 having 
the greatest score, 0.998 (Figure 1A). No threonine or tyrosine residues reached a score greater 
than 0.9, and these residues were not pursued in further analyses. Interestingly, serine-11 resides 
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within the Grg-interacting TN domain. This residue is conserved from Homo sapiens to Xenopus 
(Figure 1B), and a serine is present in all Nkx2 family members at either the 11, 12 or 13 
position, which is surrounded by a similar motif, in mouse and human (Figure 1C). The fact that 
S11 is predicted to be phosphorylated and retains such a high degree of conservation, points to a 
functional role for this residue. Additional bioinformatic analysis predicted that PKC is the 
responsible kinase for S11phosphorylation (Figure 2A) (Blom et al., 2004). To examine whether 
S11 is phosphorylated, we used site directed mutagenesis to convert S11 to an alanine 
(Nkx2.2S11A), mimicking the dephosphorylated state, and introduced the mutant protein into beta 
TC6 cells. Nkx2.2S11A was immunoprecipitated and subjected to Western analysis using a PKC-
phospho-specific primary antibody. In comparison to wild type Nkx2.2 protein, Nkx2.2S11A 
exhibited a dramatic decrease in the amount of phosphorylation, even in the presence of 
phosphatase inhibitors (Figure 2B).  
The PKC family of serine/threonine kinases is composed of ten isoforms and can be divided into 
three groups: the conventional PKCs (cPKC) include PKCα, β and γ; the novel PKCs (nPKC) 
include PKCδ, ε, θ and η; and the atypical PKCs (aPKC) include PKCζ, ι and λ (Mellor and 
Parker, 1998). Analysis of isoform expression in alpha TC1 and beta TC6 cell lines, indicated the 
mRNAs of PKCε and PKCζ, which are important in beta cell biology (Furukawa et al., 1999; 
Hennige et al., 2002; Schmitz-Peiffer et al., 2007), were the most abundant family members. 
These data suggest that Nkx2.2 is phosphorylated at S11, possibly by PKCε or PKCζ.  
We next wanted to determine the function of Nkx2.2 phosphorylation. Since the S11 residue is 
located within the TN (Grg-interaction) domain, it seemed plausible that phosphorylation at this 
site would affect binding with Grg proteins. To address this, we generated Nkx2.2 proteins that 
represented constitutive S11 phosphorylation (Nkx2.2S11D) or dephosphorylation (Nkx2.2S11A). 
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Western blot analysis demonstrated that transfected myc-tagged Nkx2.2 cDNA constructs were 
expressed, although at lower levels compared to endogenous Nkx2.2 (Figure 3). Due to technical 
difficulties, protein interaction could not be assessed, and phosphorylation-dependent protein 
interactions are currently being pursued. However, we were able to determine whether the 
phosphorylation status of S11 affected cofactor recruitment to gene promoters regulated by 
Nkx2.2 by assessing the appropriate recruitment of Grg3 and HDAC1 to the Arx promoter in 
alpha TC1 versus beta TC6 cell lines. We had previously shown that Nkx2.2 forms a repressor 
complex with Grg3 and HDAC1 on the Arx promoter preferentially in beta cells (Papizan et al., 
2011). In beta cells Nkx2.2S11A did not affect Grg3 recruitment; however, Nkx2.2S11D resulted in 
a significant decrease in Grg3 enrichment (Figure 4A). Grg proteins have the ability to bind and 
recruit HDACs (Chen and Courey, 2000), but surprisingly, the disruption of Grg3 recruitment 
was not correlated with a decrease in HDAC1 recruitment in beta cells, suggesting that in this 
context, HDAC1 may be recruited independently of Grg3. Examination of the Arx promoter in 
alpha cells, where HDAC1 is normally absent, revealed that Nkx2.2S11A caused a significant 
increase in HDAC1 recruitment, which was not associated with an increase in Grg3 (Figure 4B). 
The fact that Nkx2.2S11A does not result in an enrichment of Grg3 in alpha cells could be a 
reflection of endogenous Grg3 expression levels. Supporting this, it was recently demonstrated 
that only 53% of glucagon-expressing alpha cells expressed Grg3 in e15.5 embryos, and that 
percentage decreased to 22% in neonatal mice (Metzger et al., 2012), indicating that Nkx2.2 can 
recruit HDAC1 in a Grg3-independent mechanism.  
Since HDACs and Grgs are know to be involved in chromatin remodeling complexes (Hayakawa 
and Nakayama, 2011; Patel et al., 2012), we next wanted to determine if changes in their 
recruitment were associated with the underlying chromatin signature by examining activator and 
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repressor histone marks. The beta cell-specific Nkx2.2S11D –induced decrease in Grg3 
recruitment was associated with a decrease in the repressive mark H3K27me3, and the alpha 
cell-specific Nkx2.2S11A-induced increase in HDAC1 was associated with an increase in 
H3K27me3 (Figure 4C). Additionally, the increases in HDAC1 and H3K27me3 in alpha cells 
correlated with a modest decrease in Arx expression (Figure 4D). These results suggest that 
regardless of cell type, Nkx2.2S11D is associated with the loss of repressive marks, while 
Nkx2.2S11A is associated with the gain of repressive marks on the Arx promoter. Thus, Nkx2.2 
S11 phosphorylation may serve to activate Arx, while S11 dephosphorylation might facilitate its 
repression.  
We next wished to determine whether Nkx2.2 S11 phosphorylation is functioning in a similar 
manner with regards to a beta-cell transcriptional target. Deletion of NeuroD demonstrated its 
requirement for maintenance of functional beta cells; NeuroD-/- mice have reduced insulin 
production and a decrease in beta cell mass due to apoptosis (Naya et al., 1997). While NeuroD 
is first expressed in the early (e9.5) alpha cell population, by birth its expression becomes 
predominantly restricted to the insulin-expressing beta cells. (Itkin-Ansari et al., 2005; Naya et 
al., 1997). Nkx2.2 has previously been shown to activate the expression of NeuroD and to be 
required for maintaining high levels of NeuroD in mouse and zebrafish beta cells (Anderson et 
al., 2009), while repressing its expression in alpha cells (K.R. Anderson, unpublished data). 
Therefore, we hypothesized that Nkx2.2 may be recruiting co-repressors to the NeuroD promoter 
in alpha cells and co-activators in beta cells. Interestingly however, neither Grg3 nor HDAC1 
were recruited to the NeuroD promoter in either cell line, indicating that Nkx2.2 may be 
regulating NeuroD through an alternative mechanism (Figure 5A,B). Conversely, we were able 
to detect a strong enrichment in the activator mark, H3K4me3 to the NeuroD promoter in beta 
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cells. H3K4me3 was also present on the promoter in alpha cells, although at a significantly lower 
amount (Figure 5C). This differential recruitment appears to depend on Nkx2.2 phosphorylation 
state; the expression of Nkx2.2S11A in alpha cells caused a significant increase in the amount of 
H3K4me3 at the NeuroD promoter, while expression of Nkx2.2S11D in beta cells reduced 
H3K4me3 levels (Figure 5C). The repressive H3K27me3 mark was undetectable in both alpha 
and beta cells, suggesting that the promoter is actively induced rather than derepressed (Figure 
5D).  
To determine if the changes in histone marks were sufficient to alter gene expression, we tested 
whether changes in H3K4me3 were associated with NeuroD promoter activity. Co-transfection 
of Nkx2.2S11A and a NeuroD-luciferase construct resulted in an increase in promoter activity, and 
conversely, co-transfection of Nkx2.2S11D and NeuroD-luciferase resulted in a loss of activity 
(Figure 6A). However, no changes in endogenous NeuroD expression levels were detected in 
either alpha or beta cells with either mutant (Figure 6B, C). This may be attributed to the 
additional requirements of other genomic factors to regulate NeuroD expression. Since Nkx2.2 
and NeuroD have both been ascribed roles for regulating insulin expression, we additionally 
examined whether the Nkx2.2 S11 mutants altered its expression. While insulin expression 
remained undetectable in alpha cells, neither mutant altered its expression in beta cells (Figure 
6D). These results suggest that Nkx2.2S11D is associated with the loss of active marks, while 
Nkx2.2S11A is associated with the gain of active marks on the NeuroD promoter. Collectively, 
since we observe that Nkx2.2S11D is associated with activation, and Nkx2.2S11A is associated with 
repression on the Arx promoter, these findings imply that two different regulatory mechanisms 
are in place on each promoter (Figure 7).  
Discussion 
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PTMs can act as a binary switch that dictates cofactor binding to transcriptional complexes. For 
example, Nf-κB phosphorylation allows binding to CBP/p300, leading to Nf-κB target gene 
activation (Zhong et al., 1998), and Pax2 phosphorylation obstructs its interaction with Grg4, 
allowing Pax2 target gene activation (Cai et al., 2003). Here, we demonstrate that Nkx2.2 is 
phosphorylated at S11, and this phosphorylation potentially acts as a context-dependent regulator 
of Nkx2.2 function. We demonstrate that Nkx2.2 S11 phosphorylation may serve to activate Arx 
and repress NeuroD. Thus, since these genes are exclusively expressed in the mature islet, 
Nkx2.2 S11 phosphorylation must be cell type-specific, e.g., in the beta cell, Nkx2.2 is 
presumably dephosphorylated where it can recruit active marks to the NeuroD promoter, while 
recruiting a repressive complex (Grg3, HDAC1 and H3K27me3) to the Arx promoter. 
Conversely, in the alpha cell, Nkx2.2 would be phosphorylated leading to a decrease in active 
marks on the NeuroD promoter and the dismissal of the repressive complex on the Arx promoter.  
In our studies, we show that Nkx2.2 S11 is predicted to be phosphorylated by PKC; however, we 
have not determined which isoform is responsible. We demonstrate that PKCε is the most highly 
expressed isoform in the beta and alpha cell lines used in these studies, observations that are 
interesting since the loss of PKCε has recently been reported to improve whole body glucose 
tolerance, and normalize glucose tolerance in high fat-fed mice, which was due to an 
enhancement of insulin availability (Schmitz-Peiffer et al., 2007). Presumably, the loss of PKCx 
would result in the dephosphorylated form of Nkx2.2, leading to NeuroD activation and Arx 
repression. Given that NeuroD is required for maintenance of beta cells and insulin production, 
dephosphorylated Nkx2.2 – induced activation of NeuroD could be a component of the 
mechanism by which PCKε-/- mice have improvements in GSIS and whole body glucose 
tolerance. However, while we were able to see an induction of the NeuroD-luciferase construct 
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with the addition of Nkx2.2S11A, we did not observe any expression changes in endogenous 
NeuroD. The requirement of other genomic factors and/or the competing endogenous Nkx2.2 in 
the cell lines could possibly explain why gene expression changes were not altered. In support of 
this, we show that endogenous levels were much greater than transfected mutants (Figure 3). 
Ideally, these experiments would best be performed after efficient knock down of endogenous 
Nkx2.2.  
We have previously performed CoIPs with transfected Nkx2.2 and Grg3 in Hek293 cells, which 
may be more amenable to either transfection or Nkx2.2 expression; however, we wished to 
determine Nkx2.2 function in relevant cell lines that contain all of the appropriate interacting 
partners and cell components. We would like to have determined if the PTMs affect Nkx2.2 
protein interactions; however, we were unable to efficiently overexpress enough Nkx2.2 protein 
in alpha or beta cells for CoIP experiments, which also presented difficulties in generating 
enough Nkx2.2 protein from alpha and beta cells for mass spectrometry analysis of PTMs. The 
effects of Nkx2.2 phosphorylation on protein interaction are currently being pursued using in 
vitro translated Nkx2.2.  
This study demonstrates that the NeuroD promoter contains the active H3K4me3 mark in both 
alpha and beta cells, which appears to be regulated by Nkx2.2 phosphorylation; S11 
phosphorylation reduces H3K4me3 levels. How Nkx2.2 regulates H3K4me3 is unknown. The 
observation that the mixed lineage leukemia protein-1 (MLL1) complex contains the WD40-
repeat protein, WDR5, an effector of H3K4 methylation (Wysocka et al., 2005), suggests that the 
MLL1 complex could be a potential candidate. Interestingly, it is the Grg3 WD-repeat domain 
that interacts with eh1 motif-containing proteins, which includes the Nkx2.2 TN domain. A 
scenario could exist in the beta cell where the dephosphorylated Nkx2.2 TN domain could 
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interact with WDR5/MLL1 on the NeuroD promoter and with Grg3 on the Arx promoter. In this 
case, other context-specific DNA binding factors could influence the choice made by 
dephosphorylated Nkx2.2 to interact with the MLL1 complex or the Grg3 complex. Alternatively, 
other Nkx2.2 PTMs could dictate interacting partners. 
 That Grg3 nor HDAC1 are present on the NeuroD promoter in alpha cells, suggests that Nkx2.2 
may be repressing its transcription by an unknown alternative mechanism. Other factors could be 
recruited, such as DNA methyltransferases, resulting in DNA methylation and silencing of the 
NeuroD promoter in alpha cells. In support of this, we have previously shown that Nkx2.2 is 
involved in the differential methylation of the Arx promoter, where the promoter is methylated in 
beta cells and hypomethylated in alpha cells (Papizan et al., 2011). A similar phenomenon could 
exist on the NeuroD promoter, in that phosphorylated Nkx2.2 could have the ability to directly or 
indirectly recruit DNA methyltransferases specifically to the NeuroD promoter in alpha cells, 
while on the Arx promoter, the absence or presence of promoter specific DNA binding factors 
would preclude the recruitment of DNA methyltransferases.  Studies of cell type-specific 
NeuroD promoter methylation are ongoing.  
These studies also highlight the importance of understanding the temporal regulation of Nkx2.2 
phosphorylation, which may help to unveil the mechanisms by which the Ngn3 positive 
endocrine progenitor makes the decision to become an alpha cell or a beta cell. Some studies 
have suggested that Ngn3 positive cells have been pre-determined to become a particular islet 
cell type (Desgraz and Herrera, 2009). In this scenario, it is likely that Ngn3 positive cells, in 
which Nkx2.2 is phosphorylated, may be destined to become an alpha cell. Understanding these 
cell fate decisions is of great importance when trying to coax hES cells towards a particular 
lineage, such as pancreatic beta cells. In this context, deciphering Nkx2.2 function is particularly 
   
90 
intriguing, in that the endocrine cell phenotype resulting from Nkx2.2 mutations looks strikingly 
similar to the hormone positive cells generated from hES cells.  The majority of hES cell – 
derived endocrine cells are ghrelin positive, and many others are polyhormonal (D'Amour et al., 
2006). Similarly, loss of Nkx2.2 leads to the replacement of beta cells with ghrelin positive cells 
(Prado et al., 2004), and mutation to the Nkx2.2-SD domain results in the generation of many 
polyhormonal cells (J. Levine and L. Sussel, unpublished). It is also important to understand 
whether it is absolutely necessary to recapitulate every in vivo event to generate hES cell-derived 
beta cells. A concept proposed by Rieck et al, suggests that instead of manually inducing 
multiple steps of a differentiation protocol, it may be feasible that the addition of a factor or set 
of local signals may be sufficient to initiate a gene regulatory network that could influence the 
cell differentiation toward a particular lineage (Rieck et al., 2012). Accordingly, it has been 
recently demonstrated that the small molecule (-)-indolactam V (ILV) enhanced the directed 
differentiation of hES cells to Pdx1 positive cells (Chen et al., 2009b). It was further 
demonstrated that ILV functioned at the stage of differentiation from gut tube endoderm to Pdx1 
positive pancreatic progenitors by acting as a PKC agonist, although the PKC isoform was 
undetermined. 
These findings demonstrate the complexities of context-dependent gene regulation and highlight 
how a PTM may confer a level of regulation upon a transcription factor, so that differential gene 
regulation can be properly executed in the same cellular context. Additionally, further 
explorations into the function of Nkx2.2 phosphorylation may reveal shortcuts in hES cell 
directed differentiation protocols that could be taken by addition of PKC modulators that would 
direct cells toward the beta cell lineage.  
Materials and methods 
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RNA isolation and expression 
Total RNA was isolated from beta TC6 or alpha TC6 cells (RNeasy, Quiagen), and cDNA was 
prepared using the SuperScript III kit (Invitrogen) and random hexamer primers. Quantitative 
PCR was performed using 200 ng cDNA, PCR master mix (Eurogentec) and the following 
TaqMan probes (ABI Assays on Demand): NeuroD - Mm01280117_m1; Ins2 - 
Mm00731595_gH; and Arx - Mm00545903_m1. CyclophilinB probe - FAM-
TGGTACGGAAGGTGGAG, (FWD) - GCAAAGTTCTAGAGGGCATGGA, (REV) - 
CCCGGCTGTCTGTCTTGGT. Primers for PKC isoforms are from (Berdiev et al., 2002) 
Western blot 
250 ng of the 3Xmyc-Nkx2.2 cDNA expression vector was transfected into beta TC6 cells using 
X-tremeGENE HP (Roche) according to the provider’s protocol. The nuclear extract of 
transfected and non-transfected beta cells was isolated using the nuclear extract kit (Active 
Motif). 6, 10, 20 or 40 ug of nuclear extract protein was run on a NuPAGE Novex 4-12% Bis-
Tris gel (Invitrogen). Proteins were transferred onto a nitrocellulose membrane (GE Healthcare) 
and probed using mouse anti-Nkx2.2 (DSHB) or anti-myc (Kelloff et al.).  
Generation of mutant constructs 
Point mutations were made to 3xmyc-tagged Nkx2.2 cDNA using the QuickChange II Site 
Directed Mutagenesis kit (Agilent Technologies) with the following primers S-11-A: (FWD) – 
CAACACAAAGACGGGGTTTGCTGTCAAGGACATCTTGGAC, (REV) – 
GTCCAAGATGTCCTTGACAGCAAACCCCGTCTTTGTGTTG [oJP 29,30]; S-11-D: (FWD) 
– CAACACAAAGACGGGGTTTGATGTCAAGGACATCTTGGAC, (REV) – 
GTCCAAGATGTCCTTGACATCAAACCCCGTCTTTGTGTTG [oJP 33,34].  
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Chromatin Immunoprecipitation 
Expression vectors containing the according mutant versions of 3Xmyc-Nkx2.2 cDNA, Grg3 
cDNA and FLAG-HDAC1 cDNA were transfected into beta TC6 or alpha TC6 cells using X-
tremeGENE HP (Roche) according to the provider’s protocol. Chromatin was prepared using the 
ChIP-IT express kit (Active Motif), and immunoprecipitation was performed as in Chapter 3. 5 
ug of rabbit anti-TLE3 M201X (Santa Cruz Biotechnology), mouse anti-FLAG (Kelloff et al.), 
mouse anti-H3K27me3, or mouse anti-H3K4me3 (Abcam) antibodies were used to 
immunoprecipitate chromatin. Quantitative analysis of ChIP products was performed using 2 uL 
of PCR-purified ChIP DNA and SYBR Green fluorescence with the following primers: Gapdh 
(FWD) – CTCCACGACATACTCAGCACC, and (REV) – TCAACGGCACAGTCAAGGC; 
NeuroD (FWD) – AAAGGGTTAATCTCTCCTGCGGGT, and (REV) – 
CATGCGCCATATGGTCTTCCCGGT; and Arx (FWD) – TCCTCCACCATTTGAGGGTA, 









Figure 1: Nkx2.2 S11 is predicted to be phosphorylated and is well conserved. A) NetPhos 
2.0 Server predictions of mouse Nkx2.2 serine phosphorylation. Where the highest achievable 
score = 1.00, S11 scores 0.998. B) S11 is conserved in Nkx2.2 among species. C) A serine is 














































Figure 2: Nkx2.2 S11 is phosphorylated by PKC. A) Predictions made by NetPhosK 1.0 
Server of the kinase that may be governing Nkx2.2 phosphorylation. S11 is predicted to be 
phosphorylated by PKC. B) Co-immunoprecipitation of 3Xmyc-Nkx2.2 followed by western 
analysis using an anti-PKC-specific phosphoserine antibody, which recognizes phosphorylated 
serines within a PKC motif. In the presence of phosphatase inhibitors, wild-type Nkx2.2 retains 
more phosphorylation compared to Nkx2.2 without inhibitors. When S11 is mutated to an 
alanine, almost all phosphorylation is ablated, even in the presence of phosphatase inhibitors. C) 

























Figure 3: Transfected and endogenous levels of Nkx2.2 in beta-TC6 cells. The endogenous 










































Figure 4: Nkx2.2 S11 mutations affect recruitment of cofactors to the Arx promoter. A) 
Nkx2.2S11D causes a decrease in Grg3 recruitment to the Arx promoter in beta TC6 cells. B) 
Nkx2.2S11A causes an increase in HDAC1 recruitment to the Arx promoter in alpha TC6 cells. C) 
On the Arx promoter Nkx2.2S11A causes increases in H3K27me3 in alpha cells, and Nkx2.2S11D 
causes decreases in H3K27me3 in beta cells. D) In alpha TC6 cells, where Arx is expressed, 





















Figure 5: Nkx2.2 S11 mutations affect local epigenetic marks on the NeuroD promoter. 
Neither Grg3 (A) nor HDAC1 (B) is present on the NeuroD promoter in alpha or beta TC6 cells. 
C) The active H3K4me3 mark is present on the NeuroD promoter in alpha and beta cells, 
although at significantly lower levels in alpha cells. Nkx2.2S11A causes an increase in H3K4me3 
in alpha cells to levels indistinguishable from beta cells. Conversely, Nkx2.2S11D causes a 
decrease in H3K4me3 in beta cells to levels comparable to alpha cells. D) The repressive 

























Figure 6: Gene expression changes in response to Nkx2.2 S11 mutations. A) Nkx2.2S11A 
induces the activation of the full-length NeuroD promoter fused to luciferase in alpha TC6 cells. 
Endogenous expression of NeuroD was not altered in beta (B) or alpha TC6 cells (C). D) 
Expression of insulin was unchanged in beta TC6 cells and was undetectable in alpha TC6 cells 






















Figure 7: Proposed model of cell specific regulation by Nkx2.2 S11 phosphorylation. Since 
Nkx2.2S11A is associated with the activation of NeuroD and the repression of Arx, we 
hypothesize that Nkx2.2 would be dephosphorylated in the beta cell to properly regulate these 
two genes. Conversely, since Nkx2.2S11D is associated with the repression of NeuroD and the 
activation of Arx, Nkx2.2 would be phosphorylated in the alpha cell. However, we cannot rule 
out, for example, that the phosphorylation of Nkx2.2 might be required for the activation of other 
beta-cell targets, such as MafA, which would require Nkx2.2 to be differentially phosphorylated 
in the same beta cell. Additional studies are needed to determine these scenarios and to elucidate 
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CONCLUSIONS AND PERSPECTIVES 
These studies have shown that the domain-dependent regulatory activities of the homeobox 
protein Nkx2.2 function in a spatial and temporal manner to control beta cell development and 
function. Mutation of the Nkx2.2 TN domain disrupts the interaction with Groucho-related gene 
(Grg) co-repressors to demonstrate that Grg-dependent Nkx2.2 regulation is required for correct 
beta cell specification and maintenance of differentiated beta cells. These studies have also 
shown that Nkx2.2 is associated with H3K27me3 modification at multiple loci, suggesting a role 
for Nkx2.2 in guiding chromatin modulators to sites of remodeling necessary for development. 
That Nkx2.2 is phosphorylated may reveal a mechanism by which Nkx2.2 gains cell- and 
promoter-specific functions. The implications of these findings are discussed below.      
Grg-mediated Nkx2.2 repression 
Grg2 and 3 are coexpressed with Nkx2.2 in the pancreas and can interact with Nkx2.2 through 
the Grg-interaction TN domain. In these studies the role of Grg-mediated Nkx2.2 regulatory 
activities was analyzed by creating mice carrying a mutation in the Nkx2.2 TN domain. In 
contrast to the Nkx2.2-/- mice, which lack all beta cells and are hyperglycemic at birth, the 
Nkx2.2TNmut/TNmut phenotype manifests later and is less severe. Several reasons could account for 
this. First, the mutation may not have completely disrupted the Nkx2.2/Grg interaction, and 
residual activity is sufficient for these early functions. Secondly, it is possible that other Nkx2.2 
protein domains can compensate for the loss of TN activity, allowing the development of a small 
number of beta cells. Accordingly, the NK2-SD domain has been reported to contain repressor 
activity (Watada et al., 2000). Studies determining the role of the Nkx2.2 SD domain are 
ongoing. Lastly, Nkx2.2 function prior to the secondary transition may not require Grg protein 
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interactions. In support of this, a recent study documenting Grg3 protein expression in foregut 
endoderm tissues demonstrated that Grg3 is not detected until e12.5 (Metzger et al., 2012). 
However, the phenotype of Nkx2.2-/- mice, and the rescue of the Nkx2.2-/- mice using an Nkx2.2 
dominant repressor, indicated that Nkx2.2 repressor activity is functioning prior to e12.5 (Doyle 
et al., 2007). This suggests that Nkx2.2 may be interacting with other repressive complexes 
during the primary transition. Since a connection between Nkx2.2 and HDAC1 has been 
determined (Chapter 2), the HDAC-containing complexes Sin3 or NuRD are possible candidates 
for Nkx2.2-mediated repression during the primary transition. Additionally, genomic regions 
where Nkx2.2 is known to bind and repress are associated with H3K27me3 marks (Chapter 4); 
therefore, PRC2 is another possible interacting candidate. We can also speculate that Nkx2.2 
uses Grg-independent repressive mechanisms to specify the alpha cell population. This is 
supported by the observations that the Nkx2.2 dominant repressor is sufficient to fully rescue the 
alpha cell population that is lacking in the Nkx2.2-/- mice, yet the Nkx2.2TNmut/TNmut mice have no 
decreases in glucagon, Irx2, Arx, Brn4 or alpha cell numbers at any developmental time point. 
Thus, Grg-independent Nkx2.2 repressor activity is needed to specify alpha cells. These studies 
highlight the need to identify additional Nkx2.2 co-repressors, specifically in a spatiotemporal 
context, which would yield a better understanding of the transcriptionally repressive networks 
required to promote the beta cell fate at the expense of other endocrine cell types.  
Nkx2.2, histone modifications and epigenetics 
It has been previously demonstrated that Grg4 is recruited to Pax2 binding sites, displacing 
components of the activating complex MLL4. Grg4 then recruits the arginine methyltransferase 
Prmt5, resulting in H4R3 di-methylation, which further recruits PRC2 and H3K27me3 to the 
region (Patel et al., 2012). This study demonstrated how a single DNA binding factor, in this 
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case Pax2, can act as either a repressor or activator, based on the presence of Grg4. Similarly, on 
the Arx promoter in beta cells, Nkx2.2 is associated with Grg3, Prmt6 and H3K27me3 (Dhawan 
et al., 2011) and (Chapter 4). The difference between these otherwise analogous Nkx2.2/Grg3 
and Pax2/Grg4 mechanisms is DNA methylation. While Patel et al. did not detect the presence of 
Dnmt3a, which has been reported to interact with Prmt5 (Zhao et al., 2009), we have shown the 
Nkx2.2/Grg3 complex contains Dnmt3a on the methylated Arx promoter (Chapter 2). DNA 
methylation is thought to silence gene expression by inhibiting transcription factor binding or by 
recruiting methyl-binding domain (MBD) proteins, which recruit chromatin-modifying 
complexes (Klose and Bird, 2006). The latter is most likely the case for beta cell-specific Arx 
repression, in that the transcription factors Nkx2.2 and Nkx6.1 are present, as well as the MBD 
protein MeCP2 (Chapter 2; (Dhawan et al., 2011). Some studies also suggest that DNA 
methylation is not the primary event in gene silencing, but rather acts to secure the silent state 
(Payer and Lee, 2008). Perhaps this is the case for Nkx2.2-induced repression of the Arx 
promoter as well, since the Nkx2.2 TN mutation retains the ability to interact with Dnmt3a, 
suggesting that even though the TN mutation causes de-repression of Arx, the promoter may still 
be methylated. This would suggest that DNA methylation alone is not sufficient to repress Arx. 
Therefore, a model could exist whereby Nkx2.2/Grg3 binds the Arx promoter, which would 
induce H3K27me3 (Chapter 4), presumably by PRC2. The de novo DNA methyltransferases 
would then recognize the modified histones, i.e., unmethylated H3K4 (Ooi et al., 2007) and 
H3K27me3 (Mohn et al., 2008) to initiate DNA methylation. This DNA methylation may be in 
place to inhibit the re-deposition of H3K4 methylation (Dhawan et al., 2011; Mohn et al., 2008), 
which may have been in place at one time during differentiation.  
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But how can Arx, which is silenced by DNA methylation, HDAC, Grg, H3K27me3, be de-
repressed in a system where a single transcription factor is carrying point mutations that causes 
the dissociation with Grg3? This suggests the mutations in the Nkx2.2 TN domain could 
additionally disrupt interactions with other co-repressors. Alternatively, and more likely, Grg3 
has the ability to recruit other co-repressors that are being lost in the Nkx2.2TNmut/TNmut mice. As 
mentioned above, in the nervous system, Prmt5 is required for recruiting Polycomb proteins in a 
Pax2/Grg4-dependent manner (Patel et al., 2012). Correspondingly, the disruption of Grg3 on the 
Arx promoter may cause the disassembling of the complex, leading to a loss of H3K27me3 and 
DNA methylation, which may give rise to the re-establishment of active marks. Notably, there 
are other genes that are upregulated in the Nkx2.2TNmut/TNmut mice that normally contain 
H3K27me3 marks in their promoter regions in FACs-purified beta cells: Irs4, which is discussed 
in chapter 3, and Nkx6.2 (van Arensbergen et al., 2010).  
In support of the idea that loss of Grg3 causes disruption of the entire complex, a similar scenario 
has been shown in yeast, where loss of recruiters causes a repressor complex to disassemble, 
resulting in gene re-activation. This was seen even in G1 or G2/M-arrested cells. The authors 
further demonstrated that re-activation was blocked with overexpression of Sir3p (a histone de-
acetylase), which was incorporated into silent chromatin even in G1-arrested cells. That the 
silencers are continuously maintained, illustrates the unexpectedly dynamic nature of 
heterochromatin (Cheng and Gartenberg, 2000). Taken together, my data point to a broad role 
for the Nkx2.2/Grg complex in mediating histone modifiers and epigenetic silencing of non-beta 
cell components. Further epigenetic studies in FACs-purified beta cells from Nkx2.2TNmut/TNmut 
mice derived at different time points during beta cell reprogramming will help us better 
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understand the features that must be overcome to initiate de-repression and cellular 
reprogramming.  
Prominin-2, Irs4 and Rbbp4 
Prominin-2 is an interesting candidate for mediating some of the beta cell functional defects in 
the Arx rescued mice, in so much as it has yet to be characterized in the pancreas, and Nkx2.2 
seems to be directly regulating its repression. Given its role as a transmembrane protein, it could 
presumably be disrupting cell-cell communication or other signaling events mediated through 
membrane receptors. However, I have not determined if prominin-2 protein is expressed in the 
Nkx2.2TNmut/TNmut beta cells. This could be done with immunofluorescence or Western analysis 
from FACs-purifed cells. To determine a role for prominin-2, beta cell specific deletion most 
likely would not yield much information, since presumably prominin-2 is either expressed at 
very low levels in the beta cell or not expressed at all. Instead, to mimic part of the 
Nkx2.2TNmut/TNmut phenotype and to determine if prominin-2 impairs beta cell function, prominin-
2 should be overexpressed specifically in the beta cells. Additionally, crossing a prominin-2 
floxed allele into the Nkx2.2TNmut/TNmut;Ins:Cre;Arxfl/fl mice would demonstrate if the combined 
loss of Arx and prominin-2 is sufficient for a more pronounced Nkx2.2TNmut/TNmut rescue than 
what is seen with Arxfl/fl alone. Similar experiments could also be done with Irs4. It has been 
determined that Irs4 antagonizes Irs1 and 2 activity, which are essential mediators of insulin 
action (Tsuruzoe et al., 2001), and loss of the insulin receptor specifically in beta cells leads to 
defects in insulin secretion and glucose intolerance (Kulkarni et al., 1999). That Nkx2.2 directly 
binds the Irs4 promoter (Hill et al., 2011) and its expression is highly upregulated in the 
Nkx2.2TNmut/TNmut mice, suggests Nkx2.2 is playing a role in maintaining the function of the 
mature beta cell by repressing Irs4. 
   
105 
I chose to follow up on the change in Rbbp4 expression for two reasons. 1) Our microarray 
showed that the increase in Rbbp4 was not rescued with beta cell-specific Arx deletion, and 2) 
Rbbp4 is a core component of chromatin remodeling complexes such as Sin3, PRC2 and NuRD, 
which suggested that Nkx2.2 is involved in global chromatin remodeling. However, I was not 
able to confirm the increase in Rbbp4 with the primer set I generated. It is interesting, though, 
that the microarray demonstrated that Rbbp4 was highly upregulated with one probe set, and 
unchanged with another. This should be resolved to unequivocally determine Rbbp4’s expression 
in the Nkx2.2TNmut/TNmut mice. If Rbbp4, a component of many repressor complexes, is indeed 
upregulated, it may explain the fact that so many genes are suppressed in a mouse model that 
presumably has lost the ability to repress Nkx2.2-target genes (Figure1A,B Chapter 3). In 
contrast to Arx and presumably Irs4 and Prominin 2, which are not normally expressed in the 
beta cell, beta cell-specific deletion of Rbbp4 would probably cause additional problems since it 
is such a gregarious protein. Even though the microarray demonstrates its up-regulation, and I 
have shown Nkx2.2 directly binds its promoter, which suggests Rbbp4 is repressed in the beta 
cell, Rbbp4 repression is perhaps intermittent, allowing for the correct levels of expression. 
Conversely, beta cell-specific overexpression of Rbbp4 might determine if the many pathways 
that are down-regulated in the Nkx2.2TNmut/TNmut (Figure 1B, Chapter 3), are mediated by Rbbp4-
dependent repression.   
Nkx2.2 phosphorylation 
The observation that Nkx2.2 is phosphorylated is a novel and exciting finding; however, more 
detailed analyses need to be completed. Admittedly, technical problems precluded some 
experiments I had planned to perform. I would like to have determined whether constitutive 
phosphorylation or dephosphorylation, afforded by serine-to-aspartate or –alanine mutations, 
   
106 
respectively, affected the interaction between Nkx2.2 and other cofactors such as Grg3, HDAC, 
Dnmt3a or CBP/p300. However, I was able to determine that constitutive phosphorylation and 
dephosphorylation affected recruitment of cofactors to Nkx2.2 target genes in a cell-specific 
context. These changes were accompanied by alterations in histone modifications. Thus, I 
hypothesize that phosphorylation inhibits the interaction with Grg3, which in turn, disrupts the 
assemblage of a repressor complex that may include components of PRC2, given changes in 
H3K27me3. In my model I predict that Nkx2.2 might be phosphorylated in alpha cells and 
dephosphorylated in beta cells (Figure 7, Chapter 4). Serine 11 is predicted to be phosphorylated 
by PKC, and I observed that the isoforms PKCε and PKCζ are the most highly expressed in the 
cells lines I used. Although PKCε-/- mice have a beta-cell protective effect, which would be 
consistent with my prediction (that Nkx2.2 is dephosphorylated in beta cells), I found PKCζ to 
be expressed about two-fold higher in alpha cells (Figure 2, Chapter 4), which would be 
consistent with my prediction that Nkx2.2 is phosphorylated in alpha cells. Direct in vitro assays 
that detect incorporation of radio-labeled phosphate into Nkx2.2 in the presence of the 
appropriate isoform could correctly identify which kinase is phosphorylating Nkx2.2. To confirm 
my hypothesis, this kinase could then be overexpressed specifically in the beta cell. This would 
presumably phosphorylate Nkx2.2 and cause the repressor complex to disassemble. The caveat 
would be that this kinase would most likely have other targets, which would cause unexpected 
changes, possibly obscuring the predicted effects. A more elegant approach might be to identify 
the kinase in vitro and determine co-expression and interaction with this kinase in vivo. Then, to 
demonstrate the differential requirement of Nkx2.2 phosphorylation, Nkx2.2S11A 
(dephosphorylated) could be expressed in the alpha cell using Glu:Cre, which may cause the 
repression of Arx and activation of NeuroD, or Nkx2.2S11D (phosphorylated) could be expressed 
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in the beta cell using Ins:Cre, which might cause the derepression of Arx and repression of 
NeuroD (Chapter 4). Identifying the kinase and at which developmental stage phosphorylation is 
required could strengthen the ability to guide stem cell differentiation to the beta cell fate. 
Additionally, determining how phosphorylation might affect Nkx2.2 protein stability, subcellular 
localization and response to metabolic flux remains to be determined, but could possibly reveal 
new therapeutic targets of diabetes.  
Concluding remarks 
Developmental programs are guided by transcription factors and chromatin modulators, which 
maintain context-specific gene expression by remodeling chromatin to either facilitate repression 
or activation. Histone modifiers have no intrinsic DNA-binding ability and no specificity for a 
particular histone residue versus one on another nucleosome. Thus, gene regulation is guided by 
DNA binding transcription factors that recruit either activating or repressive complexes to 
enhancers. To determine which enhancers contribute to the development of the beta cell lineage, 
an atlas of transcription factor binding is needed. This is being facilitated by ongoing 
experiments in the lab, which make use of in vivo tagged-Nkx2.2 to enhance ChIP-seq. A tagged 
version of Nkx2.2 will provide the ability to perform ChIP-seq in small cell populations, such as 
FACs-purified pancreatic progenitors, Ngn3+ progenitors and individual endocrine cell types. 
Determining where Nkx2.2 binds throughout the genome in a spatiotemporal manner will 
increase our understanding of how Nkx2.2 guides endocrine cell fate and maintains cellular 
function. Moreover, it is important to understand which external signals guide the regulated 
activity of transcription factors and when these signals are needed. I have shown that Nkx2.2 is 
phosphorylated, and this phosphorylation seems to be cell-type specific, i.e., phosphorylation is 
pro-alpha cell, while de-phosphorylation is pro-beta cell. As PKC family members are well 
   
108 
known to be mediators of receptor signaling cascades, identifying the signals that promote the 
activation of the responsible PKC and phosphorylation of Nkx2.2 could help in understanding 
how the Ngn3+ endocrine progenitor determines whether to become an alpha versus beta cell. 
Correctly applying these signals to ES cell differentiation cocktails could then aid in diverting 
the cells toward the beta cell lineage.  In summary, I have shown how a single transcription 
factor can control beta cell development, maintenance and function by utilizing post-translational 
modifications and interactions with different cofactors. Expansion of these studies will help 
develop more precise ES cell differentiation protocols and identify novel therapeutic targets for 
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